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Abstract 
 
Chronic diseases are among the main leading causes of mortality and morbidity in 
the United Arab Emirates (UAE). Oxidative stress (defined as an imbalance in the 
reactive oxygen species production/degradation ratio) in interaction with 
inflammation, has been highlighted as one major underlying mechanism in the 
development of these diseases. Due to their antioxidant and anti-inflammatory 
properties, polyphenols could prevent the development of chronic diseases. 
Interestingly, date seeds are particularly rich in such compounds. Nonetheless, an in 
vivo study aiming at studying and understanding antioxidant and anti-inflammatory 
effects of date seeds in serum and various organs is missing. Therefore, the present 
preclinical study is a step further to investigate these effects of date seeds in animal. 
Forty rats were fed for 13 weeks with either a control diet or a diet containing date 
seed powder (DSP) (0.2%, 0.4%, 0.8%). Biomarkers of the antioxidant status, 
protein and lipid oxidative damages, low-grade inflammation markers were 
measured in the serum and organs and histopathology was done. DSP was shown as 
not altering organs’ function, as significantly increasing the antioxidant defense 
system in serum and organs and as decreasing protein and lipid oxidative damages in 
organs. Besides, DSP did not alter the immune inflammation markers. This 
highlights a preventive role of DSP against oxidative stress-related chronic diseases 
as well as suggesting its possible anti-inflammatory effects. 
 
Keywords: Date seeds powder, chronic disease, antioxidants, oxidative damages, 
inflammation, polyphenols. 
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 )cibarA ni( tcartsbA dna eltiT
 
 في نىي التمر علً الفئران محتمل لمضبداث الأكسذة والالتهبةالتأثير ال
 صالملخ
 ٔانٕفٛبد نلأيزاض انزئٛسٛخ الأسجبة ثٍٛ يٍ  )sesaesid cinorhc(انًشيُخ الأيزاضتؼتجز 
 evitadixo(الأكسذح ػًهٛخ ٔقذ تى تسهٛط انعٕء ػهٗ  . انًتحذح انؼزثٛخ الإيبراد دٔنخ فٙ
بػهٛخ نلأكسدٍٛ ػًهٛخ اَتبج انًشتقبد انتف انتٕاسٌ ثٍٛ فٙ خهم ثؤَٓب فنتٙ تؼزٔا ( )sserts
. الأيزاض ْذِ تطٕٚز فٙ ٔاحذح أسبسٛخ كآنٛخ ،فخ انٗ الانتٓبثبدبظثبلإ ٔػًهٛخ تلاشٛٓب )
 )slonehpylop ( هجٕنٛفُٕٛلن ًٚكٍ نلانتٓبثبد، ٔانًعبدح نلأكسذح انًعبدح نخصبئصٓب َظزأ
 dees etaD(انتًز َٕٖيسحٕق أٌ   نلاْتًبو، انًثٛز ٔيٍ .انًشيُخ الأيزاض ْذِ تطٕر يُغ 
 ٔفٓى دراسخ إنٗ تٓذف دراسبدأ٘  لا تٕخذأَّ  ٔثًب. انًزكجبد ْذِ ًثمثغُٙ )redwop 
 يصم انذو ٔأػعبء َٕٖ انتًز ػهٗيسحٕق انتؤثٛز انًحتًم نًعبداد الأكسذح ٔالانتٓبة فٙ 
. تؤثٛز يسحٕق َٕٖ انتًز ػهٗ انحٕٛاَبدنذراسخ  أخزٖ خطٕح ْٙ ْذِ انذراسخ فئٌ ،ٌانفئزا
 يٍ يسحٕق َٕٖ انتًز ٔ لخب غذائٙ َظبوثبستخذاو  أسجٕػب 53فؤرا نًذح  أرثؼٍٛتغذٚخ  تىٔقذ 
%). ثى 0.2%, 6.2%, 4.2( َٕٖ انتًز ثُست يختهفخ  يسحٕق ػهٗ ٚحتٕ٘اخز  غذائٙ َظبو
 ًُتدبدٔقٛبص ان ،نتٓبةنُظبو يعبداد الأكسذح ٔيعبداد الا انحٕٛٚخ انًؤشزاد قٛبص تى
 انتشزٚح إنٗ ثبلإظبفخ ٔالأخٓشح انذو فٙ انُبتدخ ػٍ ػًهٛخ الأكسذح انًؤكسذح ٛخ ٔانذُْٛخانجزٔتُٛ
 الأػعبء، ٔظبئف ٚحذث أ٘ تغٛٛز فٙ ىن يسحٕق َٕٖ انتًز أظٓزد انُتبئح أٌ ٔقذ. انًزظٙ
 خفط إنٗ فخبثبلإظ خٓشحٔالأ انذو فٙ لأكسذحا اديعبد دفبع َظبو فٙ تحسٍٛ إنٗكًب أَّ أدٖ 
ٔكذنك نى  فٙ ْذِ الأػعبء. انُبتدخ ػٍ ػًهٛخ الأكسذح ٛخ ٔانذُْٛخ انعبرحانجزٔتُٛانًُتدبد 
 انذٔر ػهٗ انعٕءفئٌ ْذِ انُتبئح تسهط  ،ػهّٛٔ ػهٗ ػلايبد الانتٓبة. ثٛزؤٚكٌٕ نّ أ٘ ث
انٗ  ثبلإظبفخ ذ٘الأكس ثبنتٕتز انًزتجطخ انًشيُخ الأيزاض ظذ نًسحٕق َٕٖ انتًز انٕقبئٙ
 نّ كًعبد نلانتٓبثبد. انًحتًهخالأًْٛخ 
الأيزاض انًشيُخ، يعبداد الأكسذح، أظزار  ز،يسحٕق َٕٖ انتً :مفبهيم البحث الرئيسيت
 .نٛفُٕٛلٕانج ،الانتٓبة، حالأكسذ
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Chapter 1: Introduction 
1.1 Overview 
Chronic diseases are the most common cause of death in the world today with 
53 million people died in 2008, mainly from cardiovascular disease, cancer, chronic 
respiratory diseases and diabetes [1]. This represents an economic burden for many 
societies and the prevalence of chronic disease is still very worrying as they increase 
globally [2]. The UAE is particularly concerned since diabetes and cancer cause a 
high number of deaths in the country. The UAE ranks 16
th
 worldwide for diabetes. 
According to the Diabetes Centre at Imperial College London 2015, 19.3% of the 
UAE population has diabetes. Meanwhile, cancer caused 13.9% of deaths in the 
Emirates in 2012. Lymphoid, hematopoietic and other related tissue cancers were the 
dominant cancers in Abu Dhabi. Recent findings also show that breast cancer leads 
to significant increases in mortality [3]. So far, no therapy or preventive approach has 
been able to prevent this worrying trend. As such, there is an urgent need to identify 
new strategies that can tackle these diseases.  
It is well established that nutrition is a major contributing factor in chronic 
diseases. Dietary modification can have a very strong influence on health throughout 
your life [4; 5]. Diet influences the health of an individual and may determine 
whether, or not, they will develop diseases like cancer, cardiovascular disease or 
diabetes later in life. Thus, the beneficial nature of fruit and vegetables has been 
emphasized. There is strong evidence of the link between fruit and vegetable 
consumption and a reduced risk of cardiovascular disease, cancer, diabetes, 
Alzheimer’s disease, cataracts and age-related functional decline [5]. This is most 
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probably related to the nutritional properties of these foodstuffs as they are high in 
micronutrients, dietary fiber and phytochemicals such as polyphenols [6; 7].  
Polyphenols are a complex family of molecules found commonly in plants. 
More than 800 different compounds have been identified. They can be divided into 
four groups that include flavonoids and phenolic acids. They have been demonstrated 
to display many different health properties. These include antioxidant and anti-
inflammatory effects. This is of great importance since oxidative stress and 
inflammation are major underlying factors in developing chronic diseases and related 
health complications [8]. 
Oxidative stress can be defined as an imbalance between the production of 
reactive oxygen species (ROS) and the body’s antioxidant defense system. Due to the 
presence of pro-oxidants in the modern environment (chemicals, radiation, etc.), our 
bodies are constantly under pro-oxidant pressure, which increase the risk of chronic 
disease. Interestingly, it is not only through direct pathways that oxidative stress and 
inflammation are produced. They can, in the end, lead to chronic disease. It can also 
happen via other interactions. This creates complex networks, which can make a 
clear understanding of the sequence of the events that leads to chronic disease very 
difficult to arrive at [7]. The antioxidant and anti-inflammatory properties of 
polyphenols result in interesting potential in terms of the functional compounds that 
can prevent and/or treat chronic disease. 
Date seeds, a local staple, have been identified as one of the best natural 
sources of polyphenols. They were used in the past to prepare a coffee-like beverage 
but nowadays they are mostly seen as a useless by-product of the date fruit. Date 
seeds contain high levels of different vitamins, minerals and fibers [9; 10; 11]. An 
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examination of the total polyphenols by ultra-high-performance liquid 
chromatography/ diode array detection/ electrospray ionization/ mass spectrometry 
(UPLC-DAD-ESI-MS) analyses estimated the date seed content of polyphenols to be 
close to 51 g kg
−1
. Date seeds also contain Flavan-3-ols, in their monomeric and 
polymeric forms, (such as proanthocyanidins), with 46.800 g kg
−1
 of epicatechin and 
3.380 g kg
−1
 of catechin [12]. Catechin and epicatechin are the polyphenols that 
display the greatest health effects [13]. Catechins and proanthocyanidins, in 
particular, have shown antioxidant capacities including a scavenging activity 
involving free radicals such as superoxide anions (O·2
−
) a hydroxyl group (OH), 
nitric oxide( NO) and alkyl peroxyl radicals [14]. Catechins also have the ability to 
reduce the oxidative stress by modulating the enzymes that generate these free 
radicals, such as iNOS and XO [13]. Furthermore, in other studies, catechins have 
been shown to reduce lipid peroxidation and elevate endogenous antioxidants such as 
glutathione [15]. The antioxidant properties of polyphenols derived from date seeds 
have already been demonstrated in vitro [16]. 
These results were confirmed by studies conducted on animals where animal 
growth and recovery was demonstrated in cases of hepatotoxicity [17; 18; 19]. Date 
seed powder has also been studied in a short trial with male Wistar rats. After a 30-
day diet containing date seed powder (7% and 14%), a reduction in liver and serum 
malondialdehyde (MDA), a marker of lipid oxidation, was clearly shown [16]. 
Because date seeds are particularly rich in polyphenols, the beneficial effects of date 
seeds in animals can be explained in terms of the role of polyphenols. The 
information about date seed powder’s health benefits suggest it is a promising factor 
in the prevention and/or treatment of major nutrition-related chronic disease. Date 
seed powder has already been used to develop a healthy pita bread [20]. However, 
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even though the nutritional composition and in vitro antioxidant effect of date seeds 
powder has already been identified [9; 12; 16], its safety and the effects of 
antioxidants remain to be studied in a longitudinal study. In addition, although the 
key role of inflammation was identified in the development of chronic disease, there 
is no extant data related to the anti-inflammatory effects of date seed powder. 
1.2 Statement of the Problem 
Facing growth in nutrition-related diseases, many countries, including the 
UAE, have prepared strategies to tackle this issue. Oxidative stress and inflammation 
are two major mechanisms contributing to these diseases. Additionally, constant 
exposure to environmental pro-oxidants sources may also exacerbate the effects. 
Polyphenols are known to be plant compounds with well-defined antioxidant and 
anti-inflammatory properties. As such, they could well contribute to the prevention 
and/or treatment of chronic disease. Date seeds are a great source of polyphenols and 
safe to consume thus it can be reasonably assumed that date seed powder will have 
safe antioxidant and anti-inflammatory effects in vivo. This study aims to 
demonstrate just such a hypothesis. 
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Chapter 2: Relevant Literature 
 
2.1 Oxidative Stress in Nutrition-related Chronic Disease 
2.1.1 Definition 
Oxidative stress can be defined as an imbalance between the metabolic 
generation of reactive oxygen/ nitrogen species (oxidants) and the ability of the 
organism’s natural defense system to protect against the negative effects of 
antioxidant systems [21]. In a normal situation, cells are exposed to pro-oxidants 
from both endogenous and exogenous sources, but are equipped with antioxidant 
defense systems that neutralize the harmful effects to the cell (Figure 1). Reactive 
oxygen and nitrogen species include superoxide, hydrogen peroxide, hydroxyl 
radical, lipid hydro peroxides, peroxynitrite and other related species that are 
normally formed as a by- product of the aerobic metabolism process, and also play 
an important role in cell signaling and hemostasis [22]. 
Figure 1: Biological Action of Free Radicals [23] 
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2.1.2 How Oxidative Stress Can Lead to Chronic Disease 
The reactive oxygen and nitrogen species produced in the body can cause 
oxidative damage in various substrates of the body (Figure1) including lipids, 
proteins and nucleic acids. The oxidation of these substrates contributes to the 
development of chronic diseases that include cancer, cardiovascular disease, 
diabetes, other age-related diseases and perhaps even to the aging process itself [24, 
25]. Some studies have shown that oxidation of low density lipoprotein (LDL) can be 
a causative agent in cardiovascular disease, and that the oxidation of DNA can 
contribute to the development of human carcinogenesis [26]. In addition, the increase 
of oxidative stress in adipose tissue is an important mechanism in obesity-associated 
metabolic syndrome. The production of ROS is specifically increased in adipose 
tissue when it is associated with an increase in NADPH oxidase expressions and a 
decrease in antioxidative enzyme expression [27]. 
2.1.2.1 Lipid Oxidation  
Lipids, especially polyunsaturated fatty acid, are more likely to be oxidized. 
Malondialdehyde (MDA) is the main product of polyunsaturated fatty acid oxidation 
and one of the lipid peroxidation biomarkers [28, 29]. MDA exhibits high reactivity 
with biomolecules such as proteins, DNA and phospholipids to form adducts that 
result in bio molecular damage [29]. MDA-DNA adducts may lead to mutations, cell 
cycle arrest, strand breaks and the induction of apoptosis. This MDA-induced DNA 
alteration may contribute significantly to altering the properties of biomolecules, 
leading ultimately to chronic disease [30, 31]. Clinical studies showed that the 
reaction between MDA and proteins is a major cause of coronary heart disease and 
strokes. Besides this, MDA levels in the plasma of patients with Diabetes Mellitus 
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has been shown to increase and MDA was also found in the atherosclerotic plaques 
promoted by diabetes [32]. 
2.1.2.2 Protein Oxidation 
Proteins are also prone to oxidization by ROS, which leads to the formation 
of protein-protein cross-linkages and the oxidation of the protein backbone, itself a 
product of protein fragmentation [33]. Protein carbonyl is the most important protein 
oxidation marker [33, 34, 35, 36]. An accumulation of protein carbonyls 
characterizes many human diseases including diabetes, inflammatory bowel disease 
(IBD), Alzheimer's disease (AD), Parkinson’s disease, essential hypertension, cystic 
fibrosis, ulcerative colitis and arthritis [36]. 
2.1.2.3 DNA Oxidation 
DNA is another molecule that can be damaged by oxidative stress and can 
cause oxidative DNA lesions that can lead to mutations. Although the body has 
different mechanisms to protect DNA such as antioxidants and/or enzymes that 
repair DNA, oxidative stress can still result in cancer. DNA oxidative damage can 
cause modifications in DNA structure including DNA-protein cross-links, base-free 
sites, base and sugar lesions and strand breaks [37]. 
2.1.3 The Role of Antioxidants 
Antioxidants are either naturally synthesized inside the living organism, or 
externally supplied through food and other supplements [38]. Endogenous and 
exogenous antioxidants act as free radical scavengers by preventing and repairing 
damage caused by free radicals. They can, therefore, enhance the immune defense 
system and lower the risk of cancer and other degenerative diseases (Figure 2). The 
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antioxidant defense system includes enzymatic antioxidants such as superoxide 
dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) [39], which act 
via a series of reactions to convert reactive oxygen species (ROS) to more stable 
molecules, such as water and oxygen (O2). Additionally, small molecular weight, 
non-enzymatic antioxidants (e.g., GSH, NADPH, thioredoxin, vitamins E and C and 
trace metals such as selenium) function as direct scavengers of ROS.  
These enzymatic and non-enzymatic antioxidant systems are important in 
maintaining the intracellular redox balance and in minimizing the cellular damage 
caused by ROS [38]. Exogenous antioxidants are mainly dietary antioxidants. These 
include micronutrients such as vitamin C (L-ascorbic acid), vitamin E, or beta-
carotene, and polyphenols [39]. Beta-carotene and vitamins E and C have been 
closely studied and strong antioxidant activity has been shown [26; 40]. Polyphenols 
are a complex family of molecules, often found in plants, that include flavonoids and 
phenolic acids that can control the harmful effects of oxidative stress [26].  
Figure 2: Oxidative Homeostasis [41] 
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2.1.4 Conclusion 
Oxidative stress occurs when the equilibrium between the oxidant 
(ROS/RNS) and the antioxidant is broken. The balance between oxidant and 
antioxidant is critical in maintaining a healthy biological system. Oxidative damage 
can result from the actions of ROS/RNS and/or a weak antioxidant system. Many 
body molecules can be affected, including lipids, proteins and DNA. This oxidative 
damage contributes to the pathogenic processes in many diseases. They can be 
reduced by antioxidant systems such as endogenous and exogenous compounds 
acting as free radical scavengers.  
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2.2 Inflammation: Another Critical Pathway Leading to Chronic Disease 
Over the last decade, the critical role played by inflammation in the 
development of chronic disease has been highlighted. There is also growing evidence 
that certain metabolic conditions, like high insulin levels, are linked to certain 
nutritional practices that promote inflammation and ultimately the development of 
chronic diseases such as obesity, diabetes, cardiovascular disease (CVD) and cancer.  
2.2.1 Inflammation: A Definition  
Inflammation is the immune response of body tissue to an injury or infection 
and can be either acute or chronic in scale. Acute inflammation is a short-lived 
physiologic response to injury or infection and can last from a few minutes to a few 
days. It is characterized by an increased blood flow, greater blood vessel 
permeability and the accumulation of white blood cells leading to swelling, heat, 
redness and pain at the affected site.  
These physical symptoms induce the generation of new cells and a synthesis 
of the collagen matrix that stimulates the healing process in the damaged tissue. 
When acute inflammation fails to arrest the infection, or heal the injury, chronic 
inflammation is created. Chronic inflammation is a long-term physiologic response 
to many factors such as microbial or viral infections, stress, toxins, poor nutrition and 
the aging process, it may last for weeks, months or even years. Ultimately, chronic 
inflammation is a failure of the body’s immune system to maintain a healthy 
homeostatic state [42]. 
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2.2.2 Role of Cytokines 
2.2.2.1 Cytokines: A Definition 
Cytokine is a general term used for a large and diverse family of small non-
antibody proteins and peptides generated by a wide range of cells types, which act as 
regulators under both normal and pathological conditions in order to modulate the 
functional activities of individual cells and tissues. It also regulates communication 
between cells. They have a central role in the inflammatory process as they exert 
anti- and pro- inflammatory effects. Cytokines are different from hormones. 
Hormones are the primary product of a specific tissue, or cell, whereas cytokines are 
produced by most cells. More importantly, on a molar basis, cytokines are far more 
potent than hormones as they act at lower molar concentrations than most hormones 
[43]. For example, the concentration of cytokine IL-1 that induces gene expression 
and a synthesis of cyclo-oxygenase-1 (COX-2) to synthesize inflammatory mediators 
(called prostaglandins and thromboxanes) is 10 pM. The ability of IL-12 to induce 
IFNγ is 20 pM [44]. 
2.2.2.2 Cytokine Types 
About 30 cytokines are recognized. These include the interleukins IL-1 to IL-
24, tumor necrosis factors (TNFs), and transforming growth factors (TGF, Beta 1–3) 
(Figure 3). In general, cytokines have a low molecular weight (200 amino acids) and 
have specific receptors. Actually, cytokine is a general name but it is still the best 
descriptor, as most cells are able to produce and respond to these proteins. Other 
labels include monokine, a cytokine made by monocytes; lymphokine, which is 
cytokine made by lymphocytes; chemokine, cytokines with chemotactic activity and 
interleukin cytokines which are made by one leukocyte acting on other leukocytes.  
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Figure 3: Pro-inflammatory Cytokines [45] 
 
2.2.2.3 Cytokine Action 
Some cytokines display an autocrine action meaning they act on the cells that 
secrete them. Others can be described as having a paracrine action where they act on 
nearby cells or have endocrine effect on more distant cells (Figure 4). Cytokines are 
usually produced in a cascade-like effect as one cytokine stimulates target cells in 
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order to create additional cytokines. Some cytokines act as growth factors, while 
others are pro-inflammatory and some more can suppress the pro-inflammatory 
action. These are anti-inflammatory molecules, as compared to some cytokines, 
which polarize the immune response to antigens. For example, IL-4, IL10 and IL-13 
are effective activators for B-lymphocytes and, in addition, they have a potent role as 
anti-inflammatory agents that can suppress the genes in pro-inflammatory cytokines 
such as IL-1, TNF and some chemokines.  
Another example is IFN-ᵍ which is similar to IFN-α and IFN-β and provides 
antiviral protection. IFN-ᵍ is also an activator in cytotoxic T cells. However, IFN-ᵍ is 
considered to be a pro-inflammatory cytokine because of its ability to increase TNF 
activity and prompt nitric oxide (NO) [46]. Pro-inflammatory cytokines are mostly 
produced by activated macrophages and are involved in the regulation of 
inflammatory reactions [47]. The early release of cytokines determines the nature of 
the inflammatory response, which can either induce protective immunity or be 
harmful by driving immunopathology. Cytokines combined with an environment that 
includes other cytokines or specific tissues can lead to a differentiation in cell types, 
which can trigger the production of other cytokine combinations that either clear 
invading pathogens or induce inflammatory disorders. Therefore, these early 
cytokines are one of the key steps in the development of disease as has been 
emphasized in the research. 
Tumor necrosis factor-α (TNFα), interleukin-1 (IL-1), IL-6, IL-12 and IL-23 
and granulocyte macrophage colony-stimulating factors (GM-CSF) are among the 
most critical inflammatory cytokines. IL-1 and TNFα are inducers of endothelial 
adhesion molecules, which are important in the adhesion of leukocytes to the 
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endothelial surface, before migrating to the tissues. All of these cytokines have major 
effects on multiple parts of the immune system and they mediate inflammation in 
gene products that are not usually produced in a healthy person. Cytokines IL-1, 
TNFα and, in some cases, IFN-ᵍ are mainly effective in simulating the expression of 
these genes and they also initiate a cascade of inflammatory mediators by targeting 
the endothelium. This happens whether it is induced by infection, ischemia, trauma, 
toxins or immune-activated T cells. Chemokines are small peptides (8000 d) and 
represent another class of pro-inflammatory cytokines that can assist leukocytes to 
pass from circulation into tissues. IL-8 is a typical example. It also activates 
neutrophils that can cause tissue damage [45; 46]. 
 
Figure 4: Cytokine Action [48]  
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2.2.3 Low-grade Inflammation and Chronic Disease 
Low-grade inflammation is an immune system response that is characterized 
by a two to fourfold rise in the level of pro-inflammatory cytokines, such as 
interleukin 6 (IL-6) and TNFα and also in acute phase reactants such as C-reactive 
protein (CRP), fibrinogen, sialic acid, haptoglobin and serum amyloid A. It is also 
characterized by low albumin concentrations, which are synthesized in the liver and 
regulated by cytokines such as IL-6 and TNF-alpha. Although these increases are far 
from the levels observed during the acute phase, severe infections and low-grade 
inflammation are associated with the development of many chronic diseases (Figure 
5).  
Chronic low-grade inflammation is increasingly recognised as a pathological 
feature of numerous common chronic diseases. One of the most important and 
sensitive systematic markers of low-grade inflammation is CRP which is a classic 
sensitive acute phase reactant in normal conditions and also present in low 
concentrations. CRP is synthesized by hepatocytes in response to pro-inflammatory 
cytokines, especially IL-6. It has the ability to indicate inflammation at an early stage 
as it rises in the serum within 24 hours. In addition, its long plasma half-life (12-18 
hours) is constant under most conditions. Therefore, the sole determinant for 
circulating CRP is the rate of synthesis. This, in turn, directly reflects the intensity of 
the pathological process stimulating CRP production. This property is useful for the 
early detection of patients who are at risk for inflammatory disease.  
CRP is both a marker and a mediator of atherosclerosis and coronary heart 
disease as it contributes to many aspects of atherogenesis including lipid uptake by 
macrophages, activating the complement pathway, releasing pro-inflammatory 
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cytokines, promoting endothelial dysfunction, inducing the expression of tissue 
factors in monocytes and the inhibition of nitric oxide production. Studies show that 
CRP levels usually increase in response to a wide variety of infections, inflammation 
and cancerous conditions. According to the Center for Disease Control and 
Prevention and the American Heart Association, a CRP level of >3 mg/L indicates a 
higher risk of CVD, whereas CRP levels of 1-3 mg/L suggest a medium risk. CRP 
levels of <1 mg/L suggest a lower risk [49]. In addition, evidence has shown that 
individuals with CRP levels of > 3 mg/L have a four to six times greater risk of 
developing diabetes than individuals with lower levels of CRP. One aspect of the 
link between heart disease and diabetes is inflammation which can result in obesity 
because the adipocytes produce messenger proteins that induce the production of 
CRP [50]. 
Figure 5: Low-grade Inflammation Impacting Various Organs [51] 
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2.2.4 The Challenge of Detecting Low-grade Inflammation  
The critical role of low-grade inflammation in the development of chronic 
disease is clear, thus making early detection particularly important. Nevertheless, as 
above, although low-grade inflammation is characterized by a two to fourfold rise in 
the level of pro-inflammatory cytokines, this level still remains far from the levels 
observed during acute or severe infections [52]. Therefore, new and more effective 
techniques for detecting low concentrations of low-grade inflammation circulation 
cytokines are emerging. Recently, cytokine and chemokine research has become an 
important tool as a diagnostic, prognostic and therapeutic agent in dealing with and 
treating human diseases. They play a crucial role in achieving a deeper understanding 
of immunology, inflammation, allergic reactions, cancers and  atherosclerosis [53].  
There are several methods for detecting and analyzing cytokines: traditional 
ELISA assays, enzyme-linked immunosorbent spot (ELIspot) assays, antibody array 
assays and bead-based assays. To identify specific cytokines involved in any 
inflammatory or immune response, it is necessary to screen panels of cytokines. This 
often requires a level of automation and/or high throughput, as well as high 
sensitivity in order to measure low concentrations of low-grade inflammation 
cytokines. As such, magnetic beads can make the process of automation and higher 
throughput screening easier thanks to features such as walk-away washing. Bead-
based assays are cost-efficient because they allow for multiplexing, i.e. the 
simultaneous detection of multiple targets. Multiplexing allows for smaller sample 
volumes and higher throughput automation. Compared to a typical ELISA, which 
require 100 to 200 microliters for each sample, Bio-Plex assays, using Luminex 
micro-beads require just 12.5 microliters, or less, per reaction. In bead-based assays, 
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immune detection does not occur on the flat surface of the membrane or microliter 
plate, but on micron-sized spheres. Each bead contains a unique blend of 
fluorophores that act as a signature and are associated with a single analyte-bead 
identifier. 1 corresponds to IL-2, identifier 2 to IL-4 and so on. Multiplexing is 
accomplished by combining different bead sets with their associated capture 
antibodies in one master mix and incubating that mix with each sample in a 
microliter plate [54]. 
2.2.5 Conclusion 
Inflammation is the immune response of body tissues to injury or infection 
and can be either acute or chronic. Cytokine is a general term used for a large and 
diverse family of non-antibody small proteins and peptides. Some cytokines act as 
growth factors, others are pro-inflammatory and some suppress pro-inflammatory 
activity and are called anti-inflammatory molecules. Tumor necrosis factor-α 
(TNFα), interleukin-1 (IL-1), IL-6, IL-12 and IL-23 and granulocyte macrophage 
colony stimulating factors (GM-CSF) are among the most critical inflammatory 
cytokines. Low-grade inflammation is an immune system response characterized by 
a two to fourfold rise in the levels of pro-inflammatory cytokines. Low-grade 
inflammation is associated with the development of many chronic diseases, including 
Alzheimer's disease, cancer, cardiovascular disease and diabetes. Therefore, the 
detection of low-grade inflammation is crucial and can be achieved via several 
different methods that detect and analyze cytokines. These methods include 
traditional ELISA assays, enzyme-linked immunosorbent spot (ELIspot) assays, 
antibody array assays and bead-based assays.  
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2.3 Inflammation and Oxidative Stress Interactions 
Free radicals are both a cause and a result of inflammation. Damage caused 
by free radicals can lead to inflammation and, in turn, chronic inflammation can 
induce the production of more free radicals, which consequently create more 
inflammation. This is a vicious cycle, which can damage many systems in the body. 
On one hand, at low concentrations, the production of ROS is essential for innate 
immune response regulation and is involved in regulating the immune system when 
signaling injury. Additionally, redox signaling is important in the signaling pathways 
engaged by various inflammatory conditions.  
The production of ROS can regulate activation of redox-regulated 
transcription factors (NF-κB and AP-1) as well as cytokine production. On the other 
hand, when ROS are produced in excessive amounts, they can react with various 
other biomolecules, thus altering their structure and function and resulting in cellular 
damage and chronic inflammatory disease [55]. The response of the immune system 
to an attack by endogenous and/or exogenous antigens is to recruit mast cells and 
leukocytes to the damaged site. This leads to a respiratory burst where oxygen uptake 
increases and consequently increases ROS production and accumulation at the 
damaged site. This, in turn, induces signaling cascades that prompt the production of 
pro-inflammatory cytokines and chemokines.  
Alternatively, the inflammatory cells themselves can also produce soluble 
mediators such as cytokines and chemokines that induce greater production of ROS. 
These key soluble mediators can activate signal transduction cascades in addition to 
inducing changes in transcription factors such as nuclear factor kappa B (NF-κB), 
signal transducers and activators of transcription 3 (STAT3), activator protein-1 (AP-
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1), hypoxia-inducible factor-1α (HIF1-α), the nuclear factors of activated T cells 
(NFAT) and NF-E2 related factor-2 (Nrf2), which can mediate immediate cellular 
stress responses. This induces cyclooxygenase-2 (COX-2) and inducible nitric oxide 
synthase (iNOS). Abnormal expressions of inflammatory cytokines including TNF-α, 
IL-1, IL-6 and chemokines have also been reported to play a role in oxidative stress-
induced inflammation [56]. 
2.4 The Inflammation-oxidative Stress Cycle and Chronic Disease 
The inflammation-oxidative stress cycle can cause damage to many bodily 
systems but can also mediate most chronic diseases including cardiovascular disease, 
cancer, diabetes and obesity through a variety of mechanisms.  
2.4.1 Cardiovascular Disease  
Evidence to support the oxidative stress and inflammatory hypothesis behind 
cardiovascular disease is found in the elevation of acute-phase reactant C-reactive 
proteins (CRP) and also in the role of oxidative stress in atherosclerosis, particularly 
via the oxidative modification of low-density lipoproteins (LDL). The oxidized LDL 
and it is components play a significant role in activating the innate immune system 
by interacting with Toll-like receptors. This interaction causes an intracellular 
signaling cascade that induces the expression of a wide range of pro-inflammatory 
molecules, including cytokines, chemokines, eicosanoids, proteases, ROS, reactive 
nitrogen species and stimulatory molecules. 
Endothelial dysfunction is a common target and has been accepted as an early 
determinant in the development of atherosclerosis. Oxidative stress can cause injuries 
to different types of cells such as endothelium cells resulting in endothelial 
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dysfunction. This dysfunction stimulates a pro-inflammatory environment as 
evidenced by the increased endothelial expressions of adhesion molecules and the 
imbalance of arachidonic acid metabolites and chemo-attractant molecules. By 
forming a positive feedback loop, vascular inflammation leads to endothelial 
dysfunction which is associated with increased ROS production.The overall pro-
inflammatory, pro-oxidant micro-environment disrupts vascular function, mainly 
through decreasing the bioavailability of vasodilator nitric oxide (NO) and 
maintaining conditions of oxidative stress through the excess generation of ROS and 
RNS [57]. 
2.4.2 Cancer 
Studies have proved a relationship between inflammation, oxidative stress 
and cancer. It has been reported that one-quarter of all cancer cases worldwide are 
related to chronic inflammation. Continued active inflammation responses induce 
ROS overproduction from inflammatory cells and leads to cell damage or cellular 
hyperplasia. During inflammation, ROS can interact with DNA in mitotic cells 
causing permanent genomic mutations such as gene deletion, point mutation or gene 
rearrangement. In addition, more free radicals will be produced as a response to the 
inflammation in order to activate the genes involved in DNA repair. In cases of 
chronic inflammation, the cellular antioxidant system decays and this increases the 
rate of ROS production that induces the DNA. Chronic inflammation prompts cells 
to transform due to the incidence of frequent damage to the DNA from inflammatory 
cells causing a higher frequency of mutation. Chronic inflammation also increases 
the prevalence of growth-supporting stimuli and growth factor production, such as 
vascular endothelial growth factors (VEGF) [58]. 
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2.4.3 Type 2 Diabetes 
Oxi-flammation (oxidative stress and inflammation) has a critical impact on 
insulin resistance and type 2 diabetes. Increased inflammation, oxidative stress, 
glucotoxicity and dyslipidemia cause a greater workload for β-cells and the β-cells 
reach a point where they are no longer able to meet the ever-increasing demand for 
insulin. This results in diabetes. Recent studies have shown that chronic low-grade 
inflammation and the activation of the innate immune system are both involved in 
the pathogenesis of type 2 diabetes. However, the exact mechanism by which 
inflammatory cytokines affect the glucose metabolism in humans is still not clear. 
Insulin is known to act as an inhibitor in CRP synthesis, which increases insulin 
deficiency and indicates that there might be a positive correlation to type 2 diabetes, 
whereby cytokine-induced insulin resistance enhances acute phase response [59]. 
2.4.4 Obesity  
One of chronic diseases is obesity. It develops due to the interaction of many 
factors including social, behavioral, psychological, metabolic, cellular and molecular 
factors. Obesity is characterized by an increase in body weight that may induce 
systemic oxidative stress that, in turn, induces the irregular production of adipokines. 
Alternatively, excessive adipose tissue can increase oxidative stress because 
adipocytes are a source of pro-inflammatory cytokines, including TNF-α, IL-1 and 
IL-6. These cytokines stimulate the production of ROS/RNS through macrophages 
and monocytes; therefore, obesity is considered as a state of chronic inflammation. 
Excessive accumulation of fat can produce cytokines such as TNF-α which generates 
ROS in tissues due to the cellular damage caused by pressure from the fat cells. As a 
result the lipid peroxidation rate will increase [60]. The increased concentrations of 
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TNF-α and IL-6 are associated with obesity and can cause many pathological 
complications including restricting the action of the insulin by suppressing insulin 
signal transduction. This might interfere with the anti-inflammatory effect of insulin 
and so promote inflammation [61]. 
2.4.5 Alzheimer's Disease (AD) 
Evidence suggests that inflammation contributes significantly to the 
pathogenesis of Alzheimer's disease (AD). Inflammation occurs in pathologically 
weak regions of the brain and is associated with an increased expression of pro-
inflammatory cytokines and acute phase proteins, which do not usually appear in a 
normal brain. Inflammatory cells produce different inflammatory mediators such as 
pro-inflammatory cytokines, chemokines, monocyte chemo-attractant proteins, 
thromboxanes, leukotrienes, prostaglandins, macrophage inflammatory proteins, 
coagulation factors, complement factors, reactive oxygen, nitric oxide species and C-
reactive proteins. Studies report that levels of IL-1α, IL-1β, IL-6 and TNF-α are 
increased in AD-affected brain tissue. These cytokines secrete other proteins onto 
senile plaques. In addition, synergistic effects can also occur between cytokines such 
as IFN-γ and β-amyloid that enhance the production of TNF-α and reactive nitrogen 
species that are also toxic to neurons. The production of pro-inflammatory mediators 
may interact on multiple levels with neurodegeneration. Therefore, pro-inflammatory 
cytokines can not only cause cell death but can also affect classical 
neurodegenerative pathways [62]. 
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2.4.6 Conclusion 
Free radicals are both the cause and a result of inflammation. Damage caused 
by free radicals can lead to inflammation and, in turn, chronic inflammation can 
produce more free radicals and thus create even more inflammation. This vicious 
cycle damages many bodily systems and can also mediate many chronic diseases 
such as cancer, diabetes, cardiovascular disease and obesity via various mechanisms.  
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2.5 Polyphenols: Antioxidant and Anti-inflammatory Plant Compounds 
2.5.1 Definition 
Polyphenols are naturally occurring products found in fruit, vegetables, 
cereals and beverages and are secondary metabolites in plants. Polyphenols 
contribute to the color, flavor, odor, bitterness, astringency and oxidative stability of 
food. There are more than 8,000 polyphenolic compounds found in various plant 
species. Polyphenols can be classified into many groups (Figure 6). The main classes 
include phenolic acids, flavonoids, curcuminoids and stilbenes. They differ in their 
number of phenol rings and structural elements that bind these rings together. The 
differences in polyphenol types are in their primary aromatic rings, oxidation status 
and functional groups [63].   
Flavonoids are made of two aromatic rings bound together by three carbon 
atoms to form an oxygenated heterocycle. They can be classified into six subclasses 
based on the function of the heterocycle. This includes flavonols, flavones, 
isoflavones, flavanones, anthocyanidins and flavanols. Favonoids are the most 
closely studied group of polyphenols. 
Phenolic acids come in two main derivatives: one from benzoic acid and the 
other from cinnamic acid, where hydroxycinnamic acids are more common than 
hydroxybenzoic acids and consist chiefly of p-coumaric, caffeic, ferulic and sinapic 
acids. 
Stilbenes contain two phenyl moieties connected by a two-carbon methylene 
bridge. The presence of Stilbenes in human food is very low and found mainly in 
26 
 
 
 
 
grapes. In fact, these compounds are produced in response to an infection and act as 
antifungal phytoalexins. 
Lignans are another type of polyphenol containing a 2, 3-dibenzylbutane 
structure formed by the dimerization of two cinnamic acid residues. One of the 
richest sources of lignan is linseed. 
Figure 6: Dietary Polyphenol Subclasses and their Best Sources [64] 
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2.5.2 Plant Sources for Polyphenols 
The distribution of polyphenols in plant tissue is not uniform, as the insoluble 
part of the phenolic acid is located in the cell wall, while soluble phenolics are found 
in plant cell vacuoles. Outer layers of plants contain higher levels of phenolic acids 
as compared to their inner parts. The polyphenol content of plants is affected by 
different factors including ripeness, environmental factors, processing and storage 
[65].  The richest source of polyphenol are spices including cloves and star anise. 
Additionally, dried herbs such as peppermint and Mexican oregano contain high 
concentrations of flavanones. Cocoa powder and chocolate are also rich in 
polyphenols, mainly catechins and proanthocyanidins. In addition, berries have a 
high concentration of anthocyanins, especially the dark colored ones such as black 
chokeberries, black elderberries, blueberries and blackcurrant. Several seeds and nuts 
are also among the richest sources of polyphenols. Flaxseed is rich in lignan 
secoisolariciresinol; chestnuts and walnuts are rich in ellagitannins; hazelnut, pecan 
nuts and almonds are rich in proanthocyanidins, while soy flour and roasted soybeans 
are rich in isoflavones [66]. 
2.5.3 Bioavailability of Polyphenols 
Bioavailability is usually defined as the portion of an ingested nutrient that 
reaches the systemic circulation of the organism, which is the specific site where it 
exerts its biological effect. Polyphenols affect health due to many factors including 
absorption, distribution, metabolism and elimination. In addition, the bioavailability 
of each polyphenol type varies, as there is no relation between the number of 
polyphenols in food and their bioavailability in the human body. The most common 
types of polyphenol in the human diet are not necessarily the most active in the 
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human because they have a lower intrinsic activity due to being poorly absorbed 
from the intestine, highly metabolized or rapidly eliminated [67]. It is the chemical 
structure of polyphenols, not its concentration, that determines the absorption rate 
and extent as well as the nature of the metabolites circulating in the plasma [26].  
The bioavailability of polyphenolic compounds is determined by measuring 
the metabolite concentration in the plasma and urine after the compound has been 
ingested. The absorption process in polyphenols is followed by an extensive process 
of conjugation and metabolizing in the intestinal cells mediated by hebetic enzymes. 
The potential toxicity of polyphenols is controlled by the liver where it is prepared 
for either biliary or urinary excretion by increasing hydrophobicity. The conjugation 
process in polyphenols mainly includes glucuronidation, sulfation and methylation 
processes [67]. 
2.5.4 The Health Benefits of Polyphenols  
2.5.4.1 Antioxidant Effects 
A considerable body of literature supports the role of oxidative stress in the 
pathogenesis of chronic disease and the role of polyphenols in their prevention. The 
preventative role of polyphenols is related to their antioxidant effect. Polyphenols’ 
antioxidant role is to protect cell components from oxidative damage caused by the 
scavenging of free radicals. Further, polyphenols interact with cells directly through 
cell receptors and enzymes that can modify the redox status of cells and improve the 
status of oxidative stress biomarkers. The antioxidant effect of polyphenols can 
improve cell survival rates by inducing apoptosis and also prevent tumor growth [8]. 
For example, flavan-3-ols, including catechin and epicatechin, were identified as the 
polyphenols with potentially the greatest beneficial health effects [12] (Figure 7). 
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Catechins and proanthocyanidins, in particular, have been widely studied for their 
antioxidant capacities and have demonstrated a scavenging effect on various forms of 
free radicals including superoxide anions (O·2
−
), the hydroxyl group (OH), nitric 
oxide (NO) and alkyl peroxyl radicals [14]. Also, catechins have the ability to reduce 
oxidative stress by modulating the enzymes that generate free radicals such as iNOS 
and XO [13]. 
Figure 7: Epicatechin Health Benefits [68] 
2.5.4.2 Anti-inflammatory Effects 
Studies have shown that polyphenols have significant anti-inflammatory 
effects in vivo and in vitro not only as antioxidants but also as modulators of 
inflammatory redox signaling pathways [69; 65]. Polyphenols exert an anti-
inflammatory effect in vivo via several different mechanisms. These include an 
inhibition of eicosanoids that generate enzymes such as phospholipase A2 and 
cyclooxygenase, nitric oxide inhibitors, cytokines and NF-κB inhibitors. As far as 
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cyclooxygenase is concerned, polyphenols can control its activity as well as its gene 
expression in different cell types [70]. 
Experiments suggest that polyphenols can inhibit nitric oxide (NO) 
production by suppressing nitric oxide synthase (NOS) enzyme expression and NOS 
activity. NO has the capacity to interact with a variety of enzymes, thereby altering 
their function and influencing inflammatory reactions. Another important mechanism 
is the ability of polyphenols to control cytokines, which are major mediators of local 
and intercellular communication in immune and inflammatory processes. Many 
polyphenolic flavonoids have been reported to inhibit the expression of pro-
inflammatory cytokines. For example, quercetin and kaempferol have been shown to 
inhibit TNF-α and also IL-6 production during inflammation. On the other hand, the 
inhibitory action of cytokines excreted by polyphenolic flavonoids is combined, on 
occasion, with anti-inflammatory cytokines [69]. 
In addition, another useful strategy for the treatment of the inflammation is 
the ability of polyphenols to inhibit NF-κB, which plays a critical role in the 
immune, inflammatory, stress, proliferative and apoptotic responses by controlling 
special transcription factors for NF-κB [65]. In various studies carried out in different 
countries [71], it has been found that a dietary pattern characterized by high levels of 
polyphenols in vegetables, fruits and legumes is inversely associated with blood 
inflammation markers such as CRP, IL-6 and adhesion factors. The anti-
inflammatory action of polyphenols appears to be compound and tissue specific. For 
example, quercetin flavonols inhibit the release of TNF-α while green tea 
polyphenols inhibit IL-8 production in human nasal fibroblasts. Also quercetin and 
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kaempferol flavonols inhibit gene expression and the secretion of TNF-α, IL-1b or 
IL-6 in some cells [72]. 
2.5.5 Polyphenols and Chronic Disease 
 Epidemiological studies have repeatedly shown an inverse association 
between the risk of chronic human disease and the consumption of a polyphenol rich 
diet. This is mainly due to anti-oxidation and the anti-inflammatory effects of the 
polyphenols [73]. The preventive and curative effects of polyphenols diseases have 
been extensively studied and they have been shown to exhibit antioxidant and anti-
inflammatory properties. 
 As well as these properties, dietary polyphenols impact on transcriptional 
networks and signaling cascades that modulate gene expression and promote anti-
inflammatory properties. Polyphenols involved in the inhibition of nuclear factor 
kappa beta (NF-kB) can regulate the inflammatory process in many chronic diseases 
including cardiovascular disease, diabetes, cancer and Alzheimer’s disease. They do 
so by modulating the expression of the pro-inflammatory genes. The efficient 
transcriptional activation of NF-kB depends on the phosphorylation of active subunit 
P65. Polyphenols may block P65 phosphorylation, rendering NF-kB transcriptionally 
inactive [74]. Studies have shown that the incidence of coronary heart disease is 
limited by the consumption of polyphenols, as they work to inhibit LDL oxidation: a 
key mechanism in atherosclerosis [26; 75]. In addition, some polyphenols, 
specifically quercetin, inhibit enzymes such as cyclooxygenase (COX) and 
lipooxygenase (LPO) that are associated with the release of interleukins and 
chemokines.  
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 It is widely accepted that a diet rich in polyphenols can prevent various types 
of cancer. Dietary polyphenols may exert their anticancer and chemoprevention 
effects through different mechanisms such as removal of carcinogenic agents, 
controlling cancer cell signaling and antioxidant enzymatic activities. They can also 
stimulate apoptosis and cell cycle arrest [76]. Polyphenols interfere with each stage 
of the carcinogenesis process including initiation, promotion and progression. 
Additionally, polyphenols effect the metabolism of pro-carcinogens by controlling 
the expression of cytochrome P450 enzymes that can activate carcinogens. The anti-
cancer effects of polyphenols are related to their antioxidant properties that protect 
DNA from oxidative damage by carcinogens. They have also been shown to inhibit 
cyclooxygenase, hydroperoxidase, protein kinase C, focal adhesion kinase, NFκB 
and cell cycle regulators [26].  
 An increasing number of epidemiological studies have concluded that a diet 
rich in polyphenols may lower the risk of developing diabetes as it affects digestion 
and the absorption of dietary carbohydrate. Polyphenols can contribute to the 
inhibition of glucose absorption in the intestinal tract and its uptake by peripheral 
tissues. In addition, polyphenols show a potent ability to inhibit the enzymes 
responsible for the digestion of dietary carbohydrates, changing then to glucose: e.g. 
α-glycosidase and α-amylase. Furthermore, some polyphenols are able to regulate 
key pathways in the carbohydrate metabolism and hepatic glucose homeostasis such 
as glycolysis, glucose oxidation, glycogenesis and the glycogen content of the liver. 
Gluconeogenesis and the glucose output of the liver are usually impaired in the case 
of diabetes. Polyphenols can improve β cell function and insulin behavior by 
protecting β-cells from hyperglycemia-induced, oxidative-induced damage and by 
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modulating key cellular signaling pathways. All these protective mechanisms 
improve glucose homeostasis and insulin resistance [77]. 
Indeed, polyphenols not only have a direct effect on pancreatic β-cells and 
stimulating the secretion of insulin through the activation of specific cellular targets, 
but also, protects these cells from damage caused by oxidative stress and 
inflammation. Both of which are typically elevated during diabetes [78]. Moreover, 
consumption of foods rich in bioactive anti-inflammatory compounds, such as 
polyphenols, has been reported to decrease the inflammation associated with obesity 
due to their anti-inflammatory and anti-oxidant properties.  
Some studies suggest that the anti-obesity effects of polyphenol-rich diets 
may be related to the ability of polyphenols to interact, directly or indirectly, with 
adipose tissues via different pathways [79]. These pathways include the suppression 
of fat absorption, the inhibition of angiogenesis in adipose tissue, the inhibition of the 
differentiation of pre-adipocytes to adipocytes, the stimulation of apoptosis of mature 
adipocytes and a reduction in the chronic inflammation associated with obesity 
through the regulation of adipokines production [80]. Adipokines are a variety of 
proteins secreted by adipocytes and they exhibit important metabolic and 
inflammatory properties: these include leptin, adiponectin and visfatin [81]. 
2.5.6 Conclusion 
Polyphenols are a large family of naturally occurring products that are 
distributed widely in plants. Principal sources of polyphenols include fruit and 
beverages such as tea, red wine and coffee. Polyphenol bioavailability is determined 
by chemical structure not concentration. Epidemiological studies have repeatedly 
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shown an inverse association between the risk of chronic human diseases, including 
cardiovascular disease, cancer, diabetes and obesity and the consumption of a 
polyphenol rich diet. This can be attributed to polyphenols having diverse health 
benefits that include both antioxidant and anti-inflammatory properties. 
2.6 Date Seeds: A Promising Functional Ingredient to Prevent/ Treat 
Chronic Disease 
2.6.1 Date Seeds 
Phoenix dactylifera is a palm from the Phoenix genus. It is cultivated in many 
countries for its sweet, edible fruit and is considered as the most important tree in 
most Arab countries [11]. Egypt is among the top five date-producing countries, 
along with Iran, Saudi Arabia, Iraq and Pakistan. According to FAO statistics in 
2014, dates are the second most abundant crop in United Arab Emirates (UAE), with 
production reaching up to 548,135.75 tons. 
Therefore, large quantities of date seeds are available as a by-product of the 
date production process. Unfortunately, they are often considered to be as waste 
product and have previously been used in a limited way as animal feed or in the 
making of caffeine-free, coffee-flavored drinks [9]. Developing new applications for 
date seeds will economically support date producing countries. 
2.6.2 Nutritional Composition 
The fruit of the date palm is composed of a fleshy pericarp and a seed. The 
date seeds represent about 15% of the total weight of the date fruit [9]. The date seed 
contains different chemical compounds such as saturated fatty acids like stearic and 
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palmitic acid, and unsaturated fatty acids such as linoleic and oleic acids, which 
inhibit the 5-α reductase enzyme. They also contain zinc (Zn), cadmium (Cd), 
calcium (Ca) and potassium (K) [82]. Date seeds contain 3.1–7.1% moisture, 2.3–
6.4% proteins, 5.0–13.2 fats, 0.9–1.8% ash and 22.5–80.2% dietary fiber. Also, date 
seeds contain high levels of phenolic acid (3102– 4430 mg gallic acid equivalents/ 
100 g), antioxidants and dietary fiber (78–80 g/100 g) [83].  
2.6.3 The Biological Effects of Date Seeds: What Do We Know? 
Date seed powder is also used in some traditional medicines and has been 
investigated for its potential health benefits [84]. It is sometimes included in animal 
feed to enhance growth and the testosterone levels in blood plasma [18]. In addition, 
date seed extract displays an ability to restore the normal functional status of a 
diseased liver and to protect against any subsequent carbon tetrachloride 
hepatotoxicity in rat livers [85]. Date seeds contain high levels of antioxidants and 
their effect on oxidative damage and antioxidant status in vivo has been researched. 
One study conducted in male Wistar rats revealed that after a 30-day period of a diet 
containing date seeds (7% and 14%), a reduction in liver and serum malondialdehyde 
(MDA) was detected [16]. Another study evaluated the antioxidant and anti-
inflammatory activities of methanolic and water extracts from the edible portions of 
date fruit (Phoenix Dactylifera L., Family Palmae), and also assessed the methanolic 
extract of date seeds in relation to adjuvant arthritis in rats: a model of chronic 
inflammation. The results revealed that oral administration of methanolic extract 
from date seeds produced a significant reduction in swelling on the foot by up to 
35.5%. Additionally, the antioxidant status (plasma, vitamin C, E and A and β-
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carotene) increased significantly on administration of different extracts, while the 
plasma level of MDA reduced by a significant factor [86].  
2.6.4 Conclusion 
Date seeds are a major local foodstuff. They also represent a promising 
functional food product thanks to their nutritional composition and high polyphenol 
content. It’s in vitro antioxidant effect has been isolated and the anti-inflammatory 
properties can be identified. However, these latter effects have not been properly 
investigated so far. In addition, the biological effects associated with date seeds have 
yet to be investigated and established in vivo.  
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Chapter 3: Methods 
 
3.1 Diets and Feeding Regimen 
3.1.1 Date Seeds 
Date seeds from the Khalas variety were obtained from Al Ain Dates Factory 
(Al Ain, UAE). The season (summer) of collecting tamr (fully ripe dates) is usually 
spread over a period of 2–3 months. Samples were collected randomly from tamr 
batches at the end of the season, with no preference to size, color, appearance or 
firmness. The seeds were first soaked in water, washed to get rid of any adhering 
date flesh, air-dried, and ground into coarse powder using a hammer mill.  
3.1.2 Animals  
The protocol used in this study was reviewed by the Animal Research Ethics 
Committee, College of Medicine and Health Sciences, United Arab Emirates 
University, Al Ain and was conducted according to the Declaration of Helsinki 
principles. It was recorded as protocol number A19-12 and was approved on June, 
the 4th, 2012. The study was conducted in accordance with the ―Guide for the Care 
and Use of Laboratory Animals‖ [87]. Normal Wistar male rats (43-113 g) were 
obtained from the College of Medicine and Health Sciences Animal Facility, UAE 
University, Al Ain. The rats were housed in plastic cages under controlled conditions 
of 12-h light/12-h dark cycle, 50% humidity and 25±3ºC. 
3.1.3 Experimental Design 
The animals were randomly divided into four groups. They were fed for 13 
weeks before sacrifice. An isocaloric and isonitrogenous basal diet, similar to the 
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American Institute of Nutrition AIN-93G purified rodent diet [88] was used. Three 
Date seed powder diets, DSP1, DSP2 and DSP3, were prepared by using 0.2%, 0.4% 
and 0.8% DSP in the diet respectively. During the experimental period, the control 
group (5 rats) received the basal diet, DSP1, DSP2 and DSP3 groups (9 rats each) 
received DSP1, DSP2 and DSP3 diets, respectively. Water and feed were provided 
ad libitum to the rats. The doses for rats which were considered here were 
determined based on 1)the recommended amount of carbohydrates for adult (210g 
per day), 2) The average food intake of rats 25g per day, according to data from a 
previous study [16]. and the initial animal weight (200g). 
3.1.4 Preparation of Serum, Plasma, Tissue Fragments and Homogenate 
At the end of the experimental period, rats were anaesthetized with 
pentobarbital and killed following blood withdrawal via heart puncture. Blood 
samples were drawn into dry (for obtaining serum) and heparinized (for obtaining 
whole blood) tubes. Portions of serum were immediately separated after centrifuging 
the blood sample and used for measuring the levels of glucose, total cholesterol and 
HDL, total protein, albumin, lactate dehydrogenase (LDH), urea, creatinine, creatine 
kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), vitamin C, lipid 
peroxidation product Malondialdehyde (MDA) and protein-bound carbonyls. Liver, 
muscle, heart and brain were removed, blotted and weighed and 200 g/ kg
 
homogenate were prepared in ice-cold 15.5 g/L KCL in 0.05 mol/L Tris buffer (pH 
7.4) using a homogenizer. Portions of organs homogenate were processed for 
measuring the levels of protein, vitamin C, vitamin E, Glutathione (GSH), MDA and 
protein-bound carbonyls. 
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3.2 Biochemical parameters 
Glucose, total cholesterol, HDL, LDH, urea, creatinine, CK, AST, ALT, ALP 
and GGT were measured in serum by using enzymatic colorimetric methods on 
Roche/Hitachi Cobas c systems (Integra 400 Plus) [89]. 
3.2.1 Glucose 
Glucose is the major carbohydrate present in the peripheral blood, oxidation 
of glucose is the major source of cellular energy in the body. The test principle is 
UV test, enzymatic reference method with hexokinase. Glucose is phosphorylated 
with adenosine triphosphate (ATP) in the reaction catalyzed by hexokinase (HK). 
The product, glucose-6-phosphate (G6P) is then oxidized with the concomitant 
reduction of nicotinamide adenine dinucleotide (NAD) to NADH in the reaction 
catalyzed by glucose-6-phosphate-dehygrogenase (G6PDH). The formation of 
NADH causes an increase in absorbance at 340 nm. The increase was directly 
proportional to the amount of glucose in the sample [89]. 
3.2.2 Cholesterol 
  Cholesterol is a steroid with a secondary hydroxyl group in the C3 position, it 
synthesized in many types of tissue but particularly in the liver and intestinal wall. 
The test principle of the enzymatic, colorimetric method is based on the cholesterol 
esters which are cleaved by the action of cholesterol esterase to yield free cholesterol 
and fatty acids. Cholesterol oxidase then catalyzes the oxidation of cholesterol to 
cholest-4-en-3-one and hydrogen peroxide. The hydrogen peroxide formed can be 
used to oxidize an indicator in the presence of POD. In this test, H2O2 oxidizes 4 
aminoantipyrine and phenol to a quinoneimine dye in the presence of peroxidase 
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(POD). The color intensity of the dye formed is directly proportional to the 
cholesterol concentration. It was determined by measuring the increase in absorbance 
at 512 nm [89]. 
3.2.3 Low Density Lipoproteins (LDL)  
Low density lipoproteins play a key role in causing and influencing the 
progression of atherosclerosis and, in particular, coronary sclerosis. The LDLs are 
derived from VLDLs (very low density lipoproteins) rich in triglycerides by the 
action of various lipolytic enzymes and are synthesized in the liver. Homogeneous 
enzymatic colorimetric assay was used to measure LDL. Cholesterol esters are 
broken down quantitatively into free cholesterol and fatty acids by cholesterol 
esterase. In the presence of oxygen, cholesterol is oxidized by cholesterol oxidase 
to Δ4-cholestenone and hydrogen peroxide. In the presence of peroxidase, the 
hydrogen peroxide generated reacts with 4-aminoantipyrine and HSDA to form a 
purple-blue dye. The color intensity of this dye is directly proportional to the 
cholesterol concentration and was measured photometrically [89]. 
3.2.4 High Density Lipoprotein (HDL) 
  High density lipoprotein is responsible for the reverse transport of cholesterol 
from the peripheral cells to the liver. The test principle is based on the homogeneous 
enzymatic colorimetric assay. In the presence of magnesium ions and dextran sulfate, 
water-soluble complexes with LDL, VLDL, and chylomicrons are formed which are 
resistant to PEG-modified enzymes. The cholesterol concentration of HDL-
cholesterol is determined enzymatically by cholesterol esterase and cholesterol 
oxidase coupled with PEG to the amino groups (approximately 40%). Cholesterol 
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esters are broken down quantitatively into free cholesterol and fatty acids by 
cholesterol esterase. In the presence of oxygen, cholesterol is oxidized by cholesterol 
oxidase to Δ4-cholestenone and hydrogen peroxide. The color intensity of the blue 
quinoneimine dye formed is directly proportional to the HDL-cholesterol 
concentration. It was determined by measuring the increase in absorbance at 583 nm 
[89]. 
3.2.5 Urea 
Urea is the major end product of protein nitrogen metabolism. It is 
synthesized by the urea cycle in the liver from ammonia which is produced by amino 
acid deamination. Urea is excreted mostly by the kidneys but minimal amounts are 
also excreted in sweat and degraded in the intestines by bacterial action. 
Determination of blood urea nitrogen is the most widely used screening test for renal 
function. The test principle is based on the Kinetic test with urease and glutamate 
dehydrogenase. Urea is hydrolyzed by urease to form ammonium and carbonate. In 
the second reaction 2-oxoglutarate reacts with ammonium in the presence of 
glutamate dehydrogenase (GLDH) and the coenzyme NADH to produce L-
glutamate. In this reaction two moles of NADH are oxidized to NAD for each mole 
of urea hydrolyzed. The rate of decrease in the NADH concentration is directly 
proportional to the urea concentration in the specimen. It was determined by 
measuring the absorbance at 340 nm [89]. 
3.2.6 Creatinine 
The test principle of this kinetic colorimetric assay is based on the Jaffé 
method. In alkaline solution, creatinine forms a yellow-red complex with picrate. 
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The rate of dye formation is proportional to the creatinine concentration in the 
specimen. To correct for non-specific reaction caused by serum/plasma pseudo-
creatinine chromogens, including proteins and ketones, the results for serum or 
plasma are corrected by -18 μmol/L (-0.2 mg/dL) [89, 90]. 
3.3.7 Lactate Dehydrogenase  
The lactate dehydrogenase (LDH) enzyme is widely distributed in tissue, 
particularly in heart, liver, muscles and kidneys.  Elevated serum levels of LDH have 
been observed in a variety of diseases. the test principle is based on the UV assay 
where the Lactate dehydrogenase catalyzes the conversion of L-lactate t pyruvate; 
NAD is reduced to NADH. The initial rate of the NADH formation id directly 
proportional to the catalytic LDH activity it is determined by photometric measuring 
the increase in absorbance [89]. 
3.2.8 Creatinine Kinase 
The CK enzyme is a dimer composed of subunits derived from either muscle 
(M) or brain (B). Three isoenzymes have been identified: MM, MB, and BB. Normal 
serum CK is predominantly the CK-MM isoenzyme. Elevated CK-serum levels are 
found in skeletal muscle disease, particularly muscular dystrophy. The test principle 
is based on the method according to the recommendations of the International 
Federation of Clinical Chemistry (IFCC), the Société Française de Biologie Clinique 
(SFBC), the Committee on Enzymes of the Scandinavian Society for Clinical 
Chemistry and Clinical Physiology (SCE), and the Deutsche Gesellschaft für 
Klinische Chemie (DGKC). The rate of the NADPH formation is directly 
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proportional to the catalytic CK activity. It was determined by measuring the 
increase in absorbance at 340 nm [89]. 
3.2.9 Aspartate Aminotransferase (AST) 
The enzyme aspartate aminotransferase (AST) is widely distributed in tissue, 
principally hepatic, cardiac, muscle, and kidney. Elevated serum levels are found in 
diseases involving these tissues. Hepatobiliary diseases, such as cirrhosis, metastatic 
carcinoma, and viral hepatitis also increase serum AST levels. Method according to 
the International Federation of Clinical Chemistry (IFCC), but without pyridoxal-5’-
phosphate.  AST in the sample catalyzes the transfer of an amino group between L-
aspartate and 2-oxoglutarate to form oxaloacetate and L-glutamate. The oxaloacetate 
then reacts with NADH, in the presence of malate dehydrogenase (MDH), to form 
NAD+. The rate of the NADH oxidation is directly proportional to the catalytic AST 
activity. It was determined by measuring the decrease in absorbance at 340 nm [89]. 
3.2.10 Alanine Aminotransferase (ALT) 
The enzyme alanine aminotransferase (ALT) has been widely reported as 
present in a variety of tissues. The major source of ALT is the liver, which has led to 
the measurement of ALT activity for the diagnosis of hepatic diseases. Elevated 
serum ALT is found in hepatitis, cirrhosis, obstructive jaundice, carcinoma of the 
liver, and chronic alcohol abuse. The test principle is based on the method according 
to the International Federation of Clinical Chemistry (IFCC), but without pyridoxal-
5´-phosphate. ALT catalyzes the reaction between L-alanine and 2-oxoglutarate. The 
pyruvate formed is reduced by NADH in a reaction catalyzed by lactate 
dehydrogenase (LDH) to form L-lactate and NAD+. The rate of the NADH oxidation 
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is directly proportional to the catalytic ALT activity. It was determined by measuring 
the decrease in absorbance at 340 nm [89]. 
3.2.11 Alkaline Phosphatase (ALP) 
Alkaline phosphatase in serum consists of four structural genotypes: the liver-
bone-kidney type, the intestinal type, the placental type and the variant from the 
germ cells. It occurs in osteoblasts, hepatocytes, leukocytes, the kidneys, spleen, 
placenta, prostate and the small intestine. The ALP test is based on colorimetric 
assay in accordance with a standardized method in the presence of magnesium and 
zinc ions, p-nitrophenyl phosphate is cleaved by phosphatases into phosphate and p-
nitrophenol. The p-nitrophenol released is directly proportional to the catalytic ALP 
activity. It was determined by measuring the increase in absorbance at 409 nm [89]. 
3.2.12 Gamma-glutamyltransferase (GGT) 
Gamma-glutamyltransferase is used in the diagnosis and monitoring of 
hepatobiliary diseases. Enzymatic activity of GGT is often the only parameter with 
increased values when testing for such diseases, and is one of the most sensitive 
indicators known. The test principle is based on enzymatic colorimetric assay 
Gamma-glutamyltransferase transfers the γ-glutamyl group of L-γ-glutamyl-3-
carboxy-4-nitroanilide to glycylglycine. The amount of 5-amino-2-nitrobenzoate 
liberated is proportional to the GGT activity in the sample. It was determined by 
measuring the increase in absorbance at 409 nm [89]. 
3.2.13 Total Protein 
Total protein content was measured in blood and organs by following the 
method of Lowry et al. [91]. The principle of Lowry’s method lies in reactivity of the 
45 
 
 
 
 
peptide nitrogen with copper (II) ions in the reagent under alkaline conditions. 
Subsequently Folin’s ciocalteu reagent is reduced by copper catalyzed oxidation of 
aromatic acids to give a blue color which can be measured at 750nm. This method is 
sensitive to low concentrations of protein (0.05-2mg of protein per ml). The 
concentration of sample is extrapolated from a standard curve build with known 
concentrations of purified protein such as Bovine Serum Albumin. A critical point in 
Lowry’s procedure is that a variety of compounds can interfere with the assay. These 
include certain buffers, drugs, lipids, sugars, salts, nucleic acids, sulphydryl reagents, 
ammonium ions, zwitter ionic buffers, thiol compounds etc. Such compounds should 
be removed or diluted before running Lowry’s assay.  
The Chemicals were used in this experiment are Bovine Serum Albumin 
(lyophilized powder), Sodium carbonate Na2CO3, Sodium hydroxide NaOH, Copper 
sulphate pentahydrate CuSO4.5H2O, Potassium sodium tartarate KNaC4H4O6.4H2O, 
Folin’s Ciocalteu reagent and PBS tablets or (Sodium chloride NaCl, Potassium 
chloride KCl, Disodium hydrogen phosphate Na2HPO4, Potassium dihydrogen 
phosphate KH2PO4 for Reagent A was prepared by dissolving 1% sodium carbonate 
in 0.1 N NaOH. Reagent B was prepared by dissolving 0.5 % CuSO4 in 1% sodium 
potassium tartarate. Reagent C was prepared from Reagent A and Reagent B by 
mixing it in a ratio of 50:1. 1mL of this solution was added to 100 µL of the sample 
and was incubated for ten minutes. 100 µL of Folin’s Reagent was added and 
incubated in dark for half an hour. Absorbance at 750 nm was taken using UV-
Visible Spectrophotometer. The results were extrapolated from the standard curve 
obtained and the unit is mg/ml. 
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3.3 Antioxidant Status Biomarkers 
3.3.1 Vitamin C 
 Vitamin C concentration was measured by Omaye et al. method [92], after 
reaction with 2,4-dinitrophenylhydrazine at 520nm. The method is based on the 
oxidation of Ascorbic acid by copper to form dehydro ascorbic acid and diketo 
gulonic acid. These products react with 2, 4, dinitrophenyl hydrazine (DNPH) to 
form a complex, which in the presence of sulfuric acid undergoes rearrangement to 
form a product with absorbance at 515nm. The reaction was carried out in the 
presence of thiourea to provide a reducing medium to prevent interference from non- 
ascorbic acid chromogen. Chemicals and reagents were used in this experiment are 
2,4-DNPH (2,4-Dinitrophenylhydrazine) reagent, 5%Thiourea solution, 0.6%Copper 
Sulfate, 65%H2SO4, 5% TCA, 5%metaphosphoric Acid in 10% TCA solution and 
Ascorbic acid. 0.1ml of serum was mixed with 0.4 ml 5% ice-cold TCA to 
precipitate the proteins, then centrifuged at 3000 rpm for 15 minutes. 0.3ml of the 
supernatant was collected and 0.125ml of DTC (DNPH-thiourea-copper sulphate 
reagents in ratio 20:1;1 which prepared fresh daily for the work) was added to it. The 
mixture was incubated at 60°C for one hour and then cool in Ice for 10 minutes. 0.5 
ml cold 65%H2SO4 was added to each tube and mixed. Tubes were kept to stand at 
room temperature for 30 minutes and reading was taken at 515nm. The results are 
extrapolated from the standard curve obtained and the unit is ug/ml. 
3.3.2 Vitamin E 
 Vitamin E was measured by HPLC using a fluorescence detector with 
excitation at 205 nm and emission at 340 nm [93]. Vitamin E Standard was prepared 
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from vitamin E (alpha- Tocopherol) standard which is a 99% oily stock from Sigma. 
Working stock of the standard was prepared with concentration 20mg/ml, 2000 mg 
of vitamin E standard, then it was added to methanol and shacked to be dissolved. 
Volume was made up to 100ml in a standard volumetric flask. The stock standard 
was diluted to provide working standards with different concentration (1, 3, 5, 10, 20 
mg/ml) for the assay. All the flasks were kept away from light and heat. Stored at 
4°C and the working standards was filtered using a 0.45 µm membrane syringe filter 
into UPLC sample vials (amber). 500µl of the sample was taken and added to 1000µl 
of ethanol. Then it was vortex well and 4 ml of Hexane was added. The mixture was 
vortex well and then Centrifuged at 3000 rpm for 5 - 10 minutes.  After that 3000µl 
of the Hexane layer (supernatant) was aliquot to a fresh tube. The Hexane was 
evaporated using pressurized Nitrogen gas till dryness. For the analysis, the residue 
was dissolved with 500µl Methanol and filtered using 0.45µm syringe filter onto 
HPLC sample vial (amber). Finally, the samples were injected in the HPLC.  
 The Liquid Chromatographic analysis was carried out using the ACQUITY 
UPLC System (Waters, Milford, MA, USA) with the PDA eλ detector (Photo Diode 
Array detector), Acquity Sample Manager, Binary Solvent Manager and the total 
system was controlled with Waters Empower Software. The analytical column was 
ACQUITY BEH C18, 1.7 µm stationary phase particle size reversed phase column 
(2.1 mm I.D. X 100 mm length), Waters USA. The mobile phase consisted of 
Solvent A: Water: Acetonitrile (90:10), Solvent B: Acetonitrile: Methanol (50:50). 
Flow rate was 0.7 ml / min, column temperature was35 °C, injection volume was 10 
µl and the detection wavelengths was 291 nm for Vitamin E and 285 nm for Vitamin 
E acetate. 
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3.3.3 Glutathione 
Glutathione was measured spectrophotometrically at 412 nm after reaction with 
dithionitrobenzoic acid. This assay is based on the measurement of the non-protein 
sulfhydryl groups (NP-SH) by spectroscopy using the method as described by 
Ellman, who used 5, 5’-dithiobis-(2-nitrobenzoic acid) DTNB for the measurement. 
In the reaction DTNB is reduced by –SH groups to form 2-nitro-5mercaptobenzoic 
acid. The product formed has an intense yellow color and can be used to measure the 
–SH groups, reading the solution at wavelength 412nm. The Chemicals were used in 
this experiment are DTNB, Methanol, Tris salt, EDTA and TCA. All procedure in 
the experiment was carried out at room temperature. 100µl of homogenate is mixed 
with 100µl of 20% TCA. The mixture was vortex and incubated in ice for 20 
minutes. The sample was centrifuged at 10,000×g for 15 minutes and 100µl of the 
sample supernatant in to 96 well plate. 100µl of 10% TCA was added to one well 
which is assigned as blank. 200µl of Tris buffer followed by 5µl of DTNB solution 
was added to the blank and sample wells in the microplate. Incubate for 5 minutes in 
an agitator shaker. Read the absorbance at 412 nm. The results were calculated using 
Beer-Lamberts law using the molar extinction co-efficient. The unit used to express 
the data is nmol /g tissue 
              (       )  (
           
             
)      
Where, 
13.6mM
-1
cm
-1
 is the molar extinction co-efficient of reduced DTNB (TNB) 
0.96945cm is the path-length for 305µl in NUNC edge 96 well plate which is 
calculated using the formula, 
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Concentration Initial corresponds to the concentration of NP-SH in the supernatant 
taken to be assayed in the 96-well plate. The final concentration in nmol/g tissue is 
calculated by,  
              (     )  (
                           
   
) 
Where, 2 is the dilution factor in step 1 of the protocol (yields the NP-SH content in 
100µl of the initial sample). 10 is the conversion factor to yield the NP-SH content in 
1ml of the homogenate. 0.1 is used to calculate the NP-SH in 1g of the tissue (Since 
homogenate was prepared as 10%, 1ml of homogenate corresponds to 0.1g of the 
tissue) [94].  
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3.4 Oxidative Damage Biomarkers 
3.4.1 MDA 
The concentration of the lipid peroxidation product MDA was measured by 
using the modified procedure of Li and Chow [95]. The reaction mixture was 
extracted with isobutanol and the fluorescence intensity was measured with 
excitation at 515 nm and emission at 550 nm using a spectrofluorometer. 1,1,3,3 
Tetramethoxypropane was used as standard. MDA standard is a 99% pure liquid 
stock from Sigma. For preparation of standard the following calculation is followed.  
Density of the MDA Std = 0.997g/ml (997g/L) 
Mass % = 99% = 0.99 
Molar mass = 164.20g/mol 
           
           
         
 
            
        
      
            
 
 
         
     
     
 
     
 
        
 
Hence the standard is a 6.011M solution. 
Conversion of units: 6.011moles/1000ml = 0.006011moles/ml 
0.006011moles/ml = 0.006011×109nmol/ml =6011×103nmol/ml 
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To prepare a working stock of the standard with concentration 1000nmol/ml, 
16.6µl of the MDA Std. is added to 0.2N HCl and volume is made up to 100ml in a 
standard flask. Dilutions of this working stock provides working standards with 
different concentration (1, 5,10,20,40 nmol/ml) for the assay. Standard were prepared 
by adding 1 ml of the TBA solution to 1 ml of the working standard, then vortex well 
and incubated for 1 hour at 60ºC. 500 µl of the mixture was transferred to new tube  
and 500µl of butanol was added to it. The mixture was vortex well and the tube was 
kept to stand for a minute. Once the phase in mixture has separated, the upper layer 
has been carefully removed using the syringe. Filter the 0.45µm filter onto HPLC  
sample vial (amber). The standards were injected.  
For the sample, 400µl of the sample was taken and added to 400µl of ice cold 
20% TCA solution. The samples were vortex well and incubated in ice for 20 
minutes. The samples were centrifuged at 11,000rpm for 15 minutes and aliquoted 
400µl of the supernatant to a fresh tube. 400µl of TBA solution was added to the 
supernatant, vortex well and incubated at 60C for 1 hour. After incubation, the 
samples allowed to cool down a little.  800µl of butanol was added to the sample and 
vortex well. Then the mixture was stand for phase separation and once the phase in 
mixture has been separated, the upper layer was carefully removed using the syringe.  
Finally, the samples were filtered using 0.45µm filter onto HPLC sample vial 
(amber) and injected. For the HPLC Conditions, the High-Performance Liquid 
Chromatographic analysis was carried out using a Waters Breeze HPLC system 
(Waters Corporation, USA): 1525 Pump, 2475 Multi λ Fluorescence detector, 717 
Auto sampler and system controller with a PC control program. The analytical 
column is XTerra MS C18, 5 µm pore size reversed phase column (4.6 *150 mm), 
Waters USA. The mobile phase consisted of Methanol – 0.05 M KH2PO4 buffer 
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PH=6.8 (40:60, v/v) containing 0.2 %( v/v) Tri ethanol amine. HPLC was isocratic a 
condition at flow rate 1 ml/min. Column temperature 35 °C.  Fluorescence detector 
wavelength was set at 532 nm (excitation) and 553 nm (emission) and the injection 
volume was 20 µl. 
3.4.2 Protein-bound Carbonyls 
The content of protein-bound carbonyls, which is used to assess the extent of 
protein oxidation, was determined spectrophotometrically at 530nm by the 2,4 
dinitrophenylhydrazine method of Levine et al [96]. The method used for the assay 
of protein carbonyl in biological samples relies on the reaction between protein 
carbonyl and 2, 4-dinitrophenylhydrazine (DNPH). DNPH reacts with protein 
carbonyls, forming a Schiff base to produce the corresponding hydrazone. The 
aliphatic hydrazones thus formed can be measured by spectroscopy between 360-
380nm. The Chemicals were used in this experiment are 2, 4-dinitrophenylhydrazine 
(DNPH), Hydrochloric Acid (HCl), Guanidine HCl, Ethanol, Ethyl acetate, 
Tricholoro acetic acid (TCA), Disodium hydrogen phosphate (Na2HPO4) and 
Sodium dihydrogen phosphate (NaH2PO4). Before proceeding, make sure all 
reagents have thawed down to room temperature in case it was refrigerated.  
For protein carbonyl assay, each sample is assayed twice – control and test 
respectively. Prepare tubes for all samples and label them appropriately. Aliquot 
100µl of the sample to control and test tubes respectively. 400µl of 2.5M HCl was 
added to the sample in control tube and 400µl of 0.2% DNPH to the sample in test 
tubes. The tubes were vortex thoroughly and incubated at room temperature under 
dark conditions for 1 hour with intermittent vortex every 10 minutes. 500µl ice-cold 
20% TCA was added to both tubes of the sample, vortex well and incubated in ice 
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for 20 minutes. The tubes were centrifuged at 13,000rpm for 15 minutes and the 
supernatant was discarded. The pellet (precipitated protein) was washed with 500µl 
wash solution. (Vortex well to make sure the solution reaches even the inside of the 
cap of the tubes). Centrifuge at 13,000rpm for 15 minutes and pellet the protein. This 
step was repeated two more times. After third wash, short spin the tubes for 30 secs 
to 1 min at high speed and all remaining wash solution was removed. Air-dry the 
protein samples in both tubes for a few minutes- until there was no visible liquid in 
the tube. The protein was dissolved in 400µl of guanidine HCl solution. Generally, 
TCA precipitated protein will take time to dissolve. The tube was vortex for 30 
seconds. 200µl of the sample was transferred from both tubes into wells in 96 well-
plate and the absorbance was read at 370nm.  The results were calculated by 
applying Beer-Lambert’s Law (explained below) and is expressed in the unit nmol 
carbonyl/mg protein. 
              (       )  (
                   
          
)      
Where, 
                                                       
22mM-1cm-1 is the molar extinction co-efficient of aliphatic hydrazones 0.5349cm 
is the path length for 200µl in Hellma 96 well quartz plate which is calculated using 
the formula, 
             
(               )
(           )
 
Concentration (Initial) corresponds to the concentration in nmol of protein carbonyl 
in 200µl of the sample in microplate. In order to get the final concentration in 
nmol/mg protein, the protein concentration value has to be substituted to the value. 
Therefore, 
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3.5 Inflammatory Markers  
Immunoassays & MILLIPLEX® map Kits was used to measure IL-6, TNF-
alpha, IFNƳ and VEGF concentrations in organ [97]. Assay started with the quality 
control preparation, before use, Quality Control 1 and Quality Control 2 were 
reconstituted with 250 μL deionized water. The vial was inverted several times to 
mix and vortex. Then allowed to sit for 5-10 minutes. Unused portion was stored at -
20°C for up to one month. Then, the 10X Wash Buffer was brought to room 
temperature and mixed to bring all salts into solution. Then 60 mL of 10X Wash 
Buffer (two bottles) was diluted with 540 mL deionized water. Rat Cytokine / 
Chemokine Standard was reconstituted with 250 μL deionized water.  The vial was 
inverted several times to mix. The vial was vortex for 10 seconds and then allowed to 
sit for 5-10 minutes. This was used as Standard 7.  
The Working Standards was prepared by first labeling 6 polypropylene 
microfuge tubes Standard 1 through Standard 6, then add 120 μL of Assay Buffer to 
each of the 6 tubes. The serial dilutions were prepared by adding 40 μL of the 
reconstituted Standard 7 to the Standard 6 tube, mixed well and transferred 40 μL of 
Standard 6 to the Standard 5 tube, mixed well and transferred 40 μL of Standard 5 to 
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the Standard 4 tube, mixed well and transferred 40 μL of Standard 4 to the Standard 
3 tube, mixed well and transferred 40 μL of Standard 3 to the Standard 2 tube, mixed 
well and transferred 40 μL of Standard 2 to the Standard 1 tube and mixed well. The 
0 ng/mL standard (Background) was the Assay Buffer. The immunoassay procedure 
started by allowing all reagents to warm to room temperature (20-25°C) before use in 
the assay. 200 μL of Assay Buffer was added into each well of the plate. Sealed and 
mixed on a plate shaker for 10 minutes at room temperature (20-25°C).   
Assay Buffer was decanting and the residual amount was removed from all 
wells by inverting the plate and tapping it smartly onto absorbent towels several 
times. 25 μL of each Standard or Control was added into the appropriate wells. Assay 
Buffer was used for 0 ng/mL standard (Background). 25 μL of Assay Buffer was 
added to the sample wells and 25 μL of appropriate matrix solution was added to the 
background, standards, and control wells. 25 μL of Sample (1:2 diluted) was added 
into the appropriate wells. Then the Mixing Bottle was vortex and 25 μL of the 
Mixed or Premixed Beads was added to each well. (Note: During addition of Beads, 
shake bead bottle intermittently to avoid settling.), after that the plate was sealed with 
a plate sealer. The plate was wrapped with foil and incubated with agitation on a 
plate shaker 2 hours at room temperature (20- 25°C). The contents were gently 
removed well and the plate was washed 2 times following instructions listed in the 
PLATE WASHING section and 25 μL of Detection Antibodies was added into each 
well. (Note: Allow the Detection Antibodies to warm to room temperature prior to 
addition.).  
The plate was sealed, covered with foil and incubated with agitation on a 
plate shaker for 1 hour at room temperature (20-25°C). 25 μL Streptavidin-
56 
 
 
 
 
Phycoerythrin was added to each well containing the 25 μL of Detection Antibodies. 
The plate was Sealed, covered with foil and incubate with agitation on a plate shaker 
for 30 minutes at room temperature (20-25°C). The contents were gently remove 
well and the plate was washed 2 times following instructions listed in the PLATE 
WASHING section. 125 μL of Sheath Fluid (or Drive Fluid if using MAGPIX®) 
was added to all wells. Resuspend the beads on a plate shaker for 5 minutes. The 
plate was run on Luminex 200TM, HTS, FLEXMAP 3DTM or MAGPIX® with 
xPONENT software. Rat cytokine / Chemokine magnetic bead panel kit 2012 [97]. 
3.6 Histopathology 
Following different organ procurement, tissue fragments were placed in 10% 
buffered formalin for 8 hours. Manual tissue processing involved dehydration by 
using ethyl alcohol, clearing by using xylene and infiltration by paraffin.  Four-
micrometer sections were obtained from paraffin blocks and stained with 
hematoxylin and eosin. Fragments of liver, muscle, heart and brain were prepared. 
3.7 Statistical Analysis 
Statistical analysis performed by using SPSS windows (Version 23; SPSS 
Inc. Chicago, Illinois, USA). Means ± standard error (s.e.) were calculated for each 
group, each parameter, in serum and in each organ. Post-hoc Tukey tests were used 
to compare the results between DSP1, DSP2, DSP3 and control groups in serum and 
in each organ. Statistical significance was set at P < 0.05. 
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Chapter 4: Results 
 
 4.1 Biochemical Results  
Biochemical parameters in the different groups are shown in Table 1. 
Glucose, cholesterol, HDL-C, total serum protein, and albumin were not significantly 
different between groups. In contrast, LDH and CK, which are biomarkers of high 
levels of tissue damage, were higher in controls compared to the DSP groups. Urea 
and creatinine are indicators of kidney function. They were reduced with DSP 
compared to the control, but the results were not significant, except for urea, which 
was significantly lower in DSP3 compared to DSP1. Some differences were 
observed for liver enzymes. The consumption of DSP was associated with a 
significant decrease in the levels of both AST and GGT compared to the control 
group in a dose-dependent manner. A similar trend was observed for ALT, which 
was significant only in DSP1 and DSP3 compared to the control. 
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Table 1: Biochemical parameters in the control and date seed powder groups 
 
                                                          
*
Means were compared between groups using post-hoc Tukey’s test.  
Statistical significance was set at P < 0.05.  
a
: Statistically significant difference with the control group 
b
: Statistically significant difference with the DSP1 group 
c
: Statistically significant difference with the DSP2 group 
 
 Control DSP1 DSP2 DSP3 
Blood glucose 
(m mol/L)  
7.74 ± 0.79 7.82 ± 0.59 9.62 ± 0.64 9.58 ±0.42 
Blood 
cholesterol 
(mmol/L) 
1.78 ± 0.05 1.60 ± 0.11 1.61 ± 0.12 1.53 ± 0.11 
Blood HDL-C 
(mmol/L) 
1.09 ± 0.06 1.11 ± 0.69 1.06 ± 0.08 0.96 ± 0.06 
Total blood 
protein (g/L) 
66.60 ± 1.92 64.38 ± 1.19 65.37 ± 1.16 64.30 ± 0.82 
Blood albumin 
(g/L) 
41.38 ± 0.99 40.53 ± 0.35 40.83 ± 0.63 41.63 ± 0.60 
Blood LDH 
(IU/L) 
3690.60 ± 
212.57
 
2647.50 ± 
249.47
a 
2507.37 ± 
202.83
a 
2074.0 ± 
179.27
a 
CK (IU/L) 
11701.25 ± 
846.36
 
3881.17 ± 
1367.47
a 
2103.20 ± 
345.90
a 
3875.90 ± 
467.51
a 
Urea (mmol/L) 4.96 ± 0.24 5.25 ± 0.23 5.09 ± 0.25
 
4.23 ± 0.25
b 
Creatinine 
(mmol/L) 
35.58 ± 1.05 32.06 ± 2.82 30.76 ± 3.03 26.31 ± 1.56 
ALT (IU/L) 62.60 ±10.67 36.30 ± 4.46
 a
 37.00 ± 6.65 37.00 ± 4.77
 a
 
ALP (IU/L) 97.05 ± 7.21 89.37 ± 5.60 89.64 ± 12.13 95.14 ± 5.85 
AST (IU/L) 337.60 ± 41.38 201.00 ± 40.16
a 
170.75 ± 20.95
a 
149.60 ± 9.24
a 
GGT (IU/L) 5.75 ± 1.25
 
1.50 ± 0.22
a 
1.25 ± 0.16
a 
1.20 ± 0.13
a 
Means ± s.e. are presented
*
. 
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4.2 Antioxidant Status Biomarkers  
The blood levels of different biomarkers of the oxidative status are presented 
in Table 2. Vitamin C and vitamin E were both increased with DSP compared to the 
control, but it was not significant. ABTS was significantly reduced in DSP2 and 
DSP3 compared to the control.  
Table 2: Biomarkers of the antioxidant status in the blood of the control and date 
seed powder groups 
 
  
                                                          
*Means were compared between groups using post-hoc Tukey’s test.  
Statistical significance was set at P < 0.05.  
a
: Statistically significant difference with the control group 
b
: Statistically significant difference with the DSP1 group 
c
: Statistically significant difference with the DSP2 group 
 
 Control DSP1 DSP2 DSP3 
Vitamin C (μg/ml) 0.05 ± 0.01 0.04 ± 0.00 0.05 ±0.01 0.08 ± 0.04 
Vitamin E (μg/ml) 2.01 ± 0.32 2.74 ± 0.20 2.64 ± 0.34 3.00 ± 0.37 
ABTS % 75.93 ± 0.75
 
73.25 ± 0.48
 
72.86 ± 0.76
a 
73.03 ± 0.61
a 
Means ± s.e. are presented.
*
 
60 
 
 
 
 
 
4.3 Biomarkers of Oxidative Status in Organs  
Table 3 shows the levels of different biomarkers of oxidative status in the 
liver, muscle, heart and brain. In the liver, both vitamin C and vitamin E were 
increased with DSP, but it was not significant. In contrast, GSH was significantly 
increased with DSP, especially in DSP3, compared to the control. In muscle, both 
vitamin C and vitamin E tended to increase compared to the control, but it was not 
significant. GSH increased with DSP and the increase was significantly different 
from the control with all three doses of DSP. In the heart, a significant difference was 
only observed for GSH, which was higher with DSP. In the brain, all the biomarkers 
measured did not change with DSP. 
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Table 3: Biomarkers of the antioxidant status in the blood of the control and date 
seed powder groups 
                                                          
*Means were compared between groups using post-hoc Tukey’s test.  
Statistical significance was set at P < 0.05.  
a
: Statistically significant difference with the control group 
b
: Statistically significant difference with the DSP1 group 
c
: Statistically significant difference with the DSP2 group 
 Control DSP1 DSP2 DSP3 
Liver  
Vitamin C 
(mcg/g)  
0.30 ± 0.026 0.25 ± 0.06 0.49 ± 0.10 0.65 ± 0.16 
Vitamin E 
(mcg/g) 
23.94 ± 2.67 41.36 ± 8.99 49.06 ± 4.80 36.01 ± 3.72 
GSH 
(nmol/g) 
568.80 ± 
5.71 
589.89 ± 
13.60 
572.91 ± 
9.78 
631.46 ± 16.18 
a,
 
c
 
Muscle  
Vitamin C 
(mcg/g) 
8.74 ± 1.02
 
10.91 ± 1.63
 
10.08 ± 0.36
 
9.31 ± 0.76
 
Vitamin E 
(mcg/g) 
5.52 ± 0.73
 
4.72 ± 0.71
 
6.67 ± 0.40
 
6.50 ± 0.37
 
GSH 
(nmol/g) 
159.91 ± 
18.14
 
258.86 ± 
17.15
a 
293.25 ± 
16.23
a 312.02 ± 8.70 
a, b 
Heart 
 
Vitamin C 
(mcg/g) 
26.20 ± 1.34
 
21.02 ± 2.53
 
24.07 ± 1.22
 
20.54 ± 0.95
 
Vitamin E 
(mcg/g) 
73.13 ± 0.08
 
64.94 ± 8.12
 
72.92 ± 0.03
 
72.96 ± 0.02
 
GSH 
(nmol/g) 
475.98 ± 
12.04
 
505.46 ± 
10.94
 
490.14 ± 
10.33
 668.83 ± 36.77
 a,b,c 
Brain  
 
Vitamin C 
(mcg/g) 
63.50 ± 3.06
 
59.28 ± 6.70
 
69.50 ± 3.27
 
66.91 ± 2.50
 
GSH 
(nmol/g) 
487.16 ± 
20.38
 
469.25 ± 
5.94
 
480.33 ± 
9.01
 476.48 ± 10.56
 
Means ± s.e. are presented.
* 
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4.4 Oxidative Damage Biomarkers 
The level of protein-bound carbonyls, biomarker of protein oxidative damage, 
in serum and organs, respectively, are shown in Figure 1 & Figure 2. Protein-bound 
carbonyls were reduced only in muscle and significantly only in DSP1 compared 
with control. In serum and other organs, it tended to decrease with DSP without 
statistical significance. 
Figure 8: Protein-bound Carbonyl in Serum (nmol/mg protein) 
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Figure 9: Protein-bound Carbonyls in Organs (nmol/mg
 
protein) 
 Means ± s.e. are presented
*
                                                          
* Means were compared between groups using post-hoc Tukey’s test. Statistical 
significance was set at P < 0.05.  
a: Statistically significant difference with the control group 
b: Statistically significant difference with the DSP1 group 
c: Statistically significant difference with the DSP2 group 
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The level of MDA, biomarkers of lipid oxidative damage, is serum and 
organs, respectively, are shown in Figure 3 & Figure 4. MDA was significantly 
reduced in the liver, muscle and brain. In the liver, MDA was decreased with DSP1 
and DSP3, while in the brain and muscle, it was significantly reduced in all treated 
groups in a dose-dependent manner compared to controls. In serum, it tended to 
decrease with DSP without statistical significance. 
Figure 10: Malondialdehyde in Serum (nmol/ml) 
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Figure 11: Malondialdehyde in Organs (nmol/ g) 
Means ± s.e. are presented
*
 
 
 
 
                                                          
* Means were compared between groups using post-hoc Tukey’s test. Statistical 
significance was set at P < 0.05.  
a: Statistically significant difference with the control group 
b: Statistically significant difference with the DSP1 group 
c: Statistically significant difference with the DSP2 group 
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 4.5 Markers of Low-grade Inflammation in the Brain and Liver  
Table 3 shows the levels of inflammatory markers, IL6, IFNγ and VEGF, in 
the brain. For IL-6 and VEGF biomarkers, their levels tended to increase with DSP, 
especially with DSP2, compared to the control, then to decrease again in DSP3 
group. But none of the differences was statistically significant. While for IFNγ there 
was a trend of decrease especially with DSP1 and DSP3 but also the decrease was 
not significant. 
 
Table 4: Markers of the Brain inflammation in control and date seeds powder groups 
 
 
 
  
 Control DSP1 DSP2 DSP3 
IL-6 (pg/ml) 
IFNγ (pg/ml) 
VEGF (pg/ml) 
3.53 ± 0.60 
1.72 ± 0.25 
2.34 ± 0.53 
4.52 ± 0.42 
1.50 ± 0.26 
3.25 ± 0.37 
4.92 ± 0.26 
1.94 ± 0.37 
3.80 ± 0.43 
4.69 ± 0.21 
1.05 ± 0.13 
2.91 ± 0.24 
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Table 4 shows the levels of inflammation markers (IL-6, IFNγ, VEGF and 
TNFα) in the liver. No difference between the groups was statistically different. 
However, there was a trend of increase in IL-6 and VEGF markers with DSP. 
 
Table 5: Markers of the Liver inflammation in control and date seeds powder groups 
  
 Control DSP1 DSP2 DSP3 
IL6 (pg/mg) 
IFNγ (pg/mg) 
VEGF (pg/mg) 
TNFα (pg/mg) 
31.66 ± 6.0 
17.02 ± 1.72 
13.00 ± 1.66 
0.36 ± 0.06 
38.24 ± 1.85 
18.98 ± 1.28 
12.64 ± 1.12 
0.43 ± 0.03 
36.07 ± 1.84 
17.50 ± 0.82 
15.31 ± 1.48 
0.43 ± 0.04 
39.23 ± 2.23 
17.96 ± 0.68 
13.98 ± 0.83 
0.45 ± 0.04 
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4.6 Histopathology 
Liver, muscle, heart and brain samples of control rats and rats from DSP1, 
DSP2 and DSP3 all showed a normal appearance (Figure 2). No changes related to 
ischemia were detected. These observations confirm the absence of any changes 
related to the oral consumption of DSP by rats. 
 
 
 
Figure 12: Histopathological Observations in Liver, Muscle, Heart and Brain 
Hematoxylin and eosin ×20. (A) Control group, (B) date seed powder 0.2%, (C) date 
seed powder 0.4%, (D) date seed powder 0.8%. 
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Chapter 5: Discussion 
 
The main purpose of this study was to investigate the safety aspects and 
effects of DSP on antioxidant status and oxidative damage in animals. The results 
clearly show that DSP did not display any significant toxic effect and did not alter 
organ function. The main biochemical indicators were not altered by the 
consumption of DSP and no tissue damage was discovered. In addition, DSP was 
shown to strengthen the defenses of the antioxidant system and protect against 
oxidative damage.  
5.1 The Safety of DSP in Animals 
Consumption of DSP was shown to be safe in rats due to no changes 
occurring in the main biochemical parameters even after consumption of DSP. Urea 
and creatinine, both nitrogenous end products of metabolism that are used in 
screening renal function, did not change significantly under the influence of DSP. As 
elevated levels of urea and creatinine indicate renal disease, this indicates that DSP is 
not toxic and does not interfere with renal function. Additionally, intracellular 
enzymes, including ALT, AST, ALP, GGT and LDH, all indicators of tissue injury, 
especially in the liver where ALT, AST and ALP are concerned were considered [98] 
[99]. An increase in these parameters has been related to hepatic, pancreatic and 
skeletal muscle diseases [100]. Their decrease due to DSP indicates that DSP did not 
alter tissue function and conversely can improve this function through protecting 
these organs. A similar decrease has been observed in a previous study exploring 
DSP [16]. 
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This could be due to the polyphenol content of DSP, especially the phenolic 
compounds. Indeed, these compounds were found to reduce the leakage of liver 
enzymes into the blood by providing protection against free radicals that may cause 
tissue damage [101; 16; 102]. 
5.2 DSP and Oxidative Balance 
Interestingly, DSP has been associated with the increased defense of the 
antioxidant system in the serum and organs. This is shown by a reduction of ABTS 
in the serum and increased GSH in the organs. The ABTS test assesses the 
antioxidant effect of natural compounds found in food or other biological systems. It 
generates when a strong oxidizing agent, such as potassium persulfate, reacts with 
the ABTS salt producing a blue-green color. The ability of natural compounds to 
reduce the dark blue-green-colored ABTS free radicals to a colorless form provides 
evidence for the strength of the antioxidant [103]. 
Glutathione is a small tripeptide synthesized from amino acids in the liver. It 
is a vital intracellular and extracellular protective antioxidant and is involved in 
many cellular functions such as control of the signaling process. It also serves as a 
co-factor in many detoxifying enzymes related to oxidative stress and xenobiotics. It 
can also help in the regeneration of important antioxidant vitamins, such as vitamins 
C and E. The depletion of GSH characterizes the aging process and many 
degenerative and apoptotic conditions. Consequently, an increase of GSH 
strengthens the antioxidant system by enhancing its protective effect against free 
radicals [104]. An elevation in such levels was observed in our study on DSP in the 
liver, muscle and heart. This increase in GSH could be related to a high level of date 
seed polyphenols increasing the expression of γ-glutamylcysteine synthetase, which 
71 
 
 
 
 
is an enzyme that limits the synthesis of GSH [105]. In addition, this might be 
explained by the fact that date seeds are rich in catechins, which have been shown in 
several studies to regulate-up anti-oxidant enzymes, including GSH. Moreover, 
catechins have been observed to increase plasma and tissue glutathione levels in 
several studies on animals [13]. Surprisingly, there was no increase of GSH in the 
brain, even though GSH is part of many central nervous system activities as both a 
neuromodulator and a neurotransmitter. It is also a major antioxidant in the brain. 
The production of free radicals is high in brain tissue due to high utilization of 
oxygen. However, GSH levels in the brain are low compared to other organs. This 
could be due to a tight regulation of GSH levels thanks to the toxicity of the 
substrates used to synthesize GSH in the  neurons [106].  
Vitamin C (ascorbic acid) is a water-soluble molecule that reacts directly with 
the free radicals. Additionally, it can regenerate a reduced antioxidant form of 
Vitamin E. Vitamin E (tocopherol) is a lipid-soluble antioxidant found in every cell 
membrane. It protects the cells from attack by free radicals and prevents lipid 
peroxidation [107]. Although it did not reach a significant level, both vitamins 
tended to increase along with an increase in DSP. In fact, Habib and Ibrahim (2011) 
reported a similar result for Vitamin E [16]. 
As far as Vitamin C is concerned, this lack of significance may be explained 
by the fact that rats, unlike humans, have the ability to synthesize ascorbic acid in 
their livers due to hepatic L-gulonolactone oxidase. Additionally, rats exhibit poor 
ascorbic acid absorption, meaning that ascorbic acid’s function in maintaining an 
antioxidant function is less important in rats than the other important functions 
carried out by this nutrient [108]. With vitamin E, the wide variability noted and the 
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sensitivity of the method utilized cannot be ignored. Additionally, Vitamin E can 
only be obtained through diet. After ingestion, a rapid increase in plasma and in the 
main storage organs, such as the muscles, is exhibited. This indicates the direct 
regulation of the exchange between plasma and metabolically active organs. In 
addition, fast recycling mechanisms that maintain Vitamin E in the blood in a 
reduced state exist [109; 110]. Furthermore, the trend observed for Vitamin E levels 
can also be related to greater levels of GSH. Indeed, GSH interacts with Vitamin E to 
maintain it in its reduced form [111]. This can be attributed to date seed catechins. 
Previous studies have shown that catechins participate in Vitamin E recycling, and 
thus complement the function of glutathione [13]. 
Finally, the protective effect of DSP against protein and lipid oxidative 
damage has been observed. Generation of ROS can cause damage to many molecules 
in the body, including proteins. One of the most widely used indicators of the 
products of protein oxidation a protein-bound carbonyl. It is generated from protein 
oxidation either through a glutamyl side chain oxidation or an α-amidation pathway. 
This oxidation process results in the formation of a peptide with an N-terminal amino 
acid, which is, in turn, blocked by α-ketoacyl derivatives. The accumulation of 
protein-bound carbonyls has been observed in many diseases, including diabetes, 
Alzheimer’s disease and arthritis [112]. In this study, protein-bound carbonyls tended 
to decrease in relation to DSP in every group, thus supporting the idea of DSP having 
a protective effect against oxidative protein damage. Nevertheless, the reduction was 
significant only in muscles with DSP at a concentration of 0.2%. This can be 
explained by the fact that skeletal muscles represent approximately 40% of 
mammalian body weight, and at least 25% of the protein turnover occurs in these 
tissues. In addition, skeletal muscles include many other proteins that are involved in 
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performing muscle functions and produce high levels of ROS due to their high 
metabolic rate [113]. Therefore, the protective effect of DSP against oxidative 
protein damage is expressed more intensely in these muscles.  
In terms of indicators of lipid peroxidation, this study used MDA. This choice 
was made, as it is the most extensively studied product of lipid peroxidation. MDA is 
one of the major aldehydes that result from the breakdown of lipid hydroperoxides. It 
is considered as a good biomarker of pathologic damage as it is linked to oxidative 
stress [114]. 
MDA was significantly reduced across every DSP concentration in the liver, 
muscle and brain. Meanwhile in the serum and heart, the reduction was not 
significant. Habib, et al. [16], who studied livers 30 days after consumption, obtained 
similar results. Serum and heart MDA levels can be affected by a blood sampling 
tube, the stability of the biomarker under different storage conditions, the sensitivity 
and ability to reproduce the method and also the steps involved in specimen 
preparation. In addition, the serum’s antioxidant levels may be affected by differing 
factors such as homeostatic regulation and the degree of absorption [28; 115; 116; 
117].  
Other studies were not able to illustrate a direct antioxidant effect of the 
biological application of polyphenols on cardiovascular health. Some foods rich in 
polyphenols have positive effects on some biomarkers of cardiovascular health. 
However, there is no concrete evidence that an improvement in antioxidant 
biomarkers and markers of oxidative damage, such as MDA, represent a true benefit 
to health [118]. 
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The results above strongly support the potential effect of DSP in protecting 
against oxidative stress and its related organ damage in vivo. This is mainly through 
its antioxidant effect and by strengthening the endogenous antioxidant system.  
5.3 DSP and the Prevention of Inflammation 
Another purpose of this study was to investigate the potential anti-
inflammatory effects of DSP in rats by evaluating low-grade inflammation cytokines 
such as IL-6, TNFα, IFN-γ and VEGF in the liver and brain. 
The role of DSP in decreasing markers of inflammation has not been fully 
investigated. This is the first study to properly investigate the anti-inflammatory 
properties of DSP. Our results did not show a significant effect of DSP intake on 
liver and brain levels in terms of IL-6, TNF-a, IFN-γ and VEGF. It should be noted 
that the inflammatory markers in our samples were in the normal physiologic 
concentration range at the outset of the study. DSP might affect these biomarkers by 
creating a higher initial pro-inflammatory status that suggest a therapeutic rather than 
preventive role for DSP in terms of inflammation. 
Low-grade inflammation was defined as a condition where pro-cytokines 
such as TNFα increase 2 to 3-fold. A lot of evidence highlights the role of TNFα in 
low-grade inflammation, in the activation of other pro-inflammatory cytokines, and 
its direct role in glucose and lipid metabolism impairment [119; 120], as well as in 
the development of metabolic syndrome. For instance, an increased level of TNFα 
has been found to increase the synthesis and accumulation of triglycerides in the 
liver, by inhibiting peripheral tissue lipolysis [120].  
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Our results clearly showed that there was no significant change in the TNFα 
levels between the control group and the DSP group in a rat liver. The TNFα level 
was maintained within minimum standard values. This indicates an absence of low-
grade inflammation.  
This might be related to an increase in Il-6, especially in the liver. IL-6 is one 
of the most important members of the cytokine family, which has a broad effect on 
many cells types, whether related to the immune system or not. IL-6 is an acute 
phase reactant cytokine that has context-dependent pro- and anti-inflammatory 
properties with pleiotropic biological effects. Additionally, it displays a hormone-
effect that contributes to homeostatic processes [121]. 
The liver is an important source of IL-6 and the primary site for clearing it 
out. IL-6 is a critical cytokine required to control and modulate other cytokines such 
as TNFα and IFN-γ. It induces the release of anti-inflammatory molecules such as 
IL-1 and a TNFα receptor antagonist [122]. It also releases the soluble receptor p55, 
a molecule that competes with the membrane bound receptors for the circulation of 
TNFα [123]. The potential uses of this mechanism are supported by studies which 
demonstrate that polyphenols, such as catechins and epicatechins, can inhibit the 
expression and secretion of pro-inflammatory molecules, like TNFα, whilst 
enhancing the production of anti-inflammatory cytokines such as IL-6 [6]. Therefore, 
the increase in Il-6 demonstrated in our study can be attributed to DSP polyphenol 
consumption, especially DSP2. This could have resulted from the suppression of 
TNFα. 
Recent studies indicate IL-6 induces hepatocyte proliferation through the 
translocation of cytoplasmic STAT 3 (a signal transducer and activator of 
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transcription protein 3) into the nucleus. This binds to DNA and induces several 
promoters that lead to a hepatoprotective effect [123]. This hepatoprotective effect 
was observed in our study and has been described above.  
Another possible mechanism for down regulation of TNFα is the ability of 
polyphenols to affect immune functions by modulating the inflammatory response in 
macrophage cells. These cells are known to play a major role in the initiation of 
inflammatory responses by producing pro-inflammatory cytokines, such as TNFα 
[124]. There is evidence that fruit and tea flavonoids, especially epicatechin, one of 
the main polyphenol classes in DSP, have immune-modulatory properties. These 
operate in terms of chemokine inhibition in different cells and regulate-down TNFα 
receptor 1 [125]. 
Another important inflammatory agent tested in this study is VEGF. VEGF 
signaling is required for normal vascular development, homeostasis and as an 
essential growth factor in vascular endothelial cells [126]. However, VEGF is a 
potent factor in increasing endothelial cell permeability that, in turn, leads to plasma 
components and leukocytes passing from blood vessel into tissues and contributing 
to inflammatory responses. Furthermore, VEGF is the most important factor in the 
angiogenesis process whereby new blood vessels are formed from pre‐existing ones. 
An abundant VEGF expression has been observed in human atherosclerotic plaques 
[6]. Contrary to other studies, which have highlighted the inhibitory effect of 
epicatechins on VEGF expression, our study found no significant change in the 
VEGF level. It maintained minimum standard values with every DSP treatment 
[127].  
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In terms of IFN-γ levels, our results showed that there was no effect from 
DSP on the different groups. Thus, DSP did not cause inflammation in rat tissue. 
This enhances its potential for safe consumption considerably. However, there was a 
decrease in the IFN-γ level in brain tissue, especially with DSP1 and DSP3, when 
compared to the control group. That said it was not a significant difference. IFN-γ is 
recognized as a chief mediator cytokine with innate as well as adaptive immunity. It 
is responsible for various key biological activities including the activation of 
macrophages. IFN-γ may also be able to enhance the pro-inflammatory transcription 
factor known as nuclear factor-κB (NF-κB) under certain conditions [128]. 
In certain previous studies, polyphenols showed immune-modulatory effects 
to protect against inflammation. For example, this included reducing the expression 
of a wide range of neuro-inflammatory markers such as IFN-γ [129]. Due to its 
capacity to modulate important inflammatory markers, DSP holds out great promise 
in terms of potentially therapeutic strategies to control inflammation and related 
diseases. Thus, our DSP treatment may also display immune-modulatory effects due 
to its polyphenol content.  
5.4 Limitations    
Some limitations of the study should be noted. Firstly, polyphenol absorption 
and the metabolism are complex processes that still require deeper investigation, 
especially in terms of issues related to polyphenol dosage and bioavailability. In 
addition, most of in vivo polyphenol studies have been conducted on a short-term 
basis and therefore more longitudinal studies are required in order to determine the 
long-term effects of these diverse compounds [6].  
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Moreover, the lack of significance in some of our findings was probably 
affected by technical limitations and the characteristics of the study such as the 
duration of the treatment. The possibility of protein degradation due to –80⁰ C 
storage of the biological samples cannot be excluded. Although most cytokines are 
stable for up to 2 years of storage at −80°C, other cytokines such as IL-6 are 
degraded by up to 50% within 2–3 years of storage. Additionally, the levels of 
circulating cytokines can be affected by sample collection protocols such as 
handling, processing, storage and even animal behaviour prior to collection. Another 
important limitation is the short half-life of cytokines. For example, the half-life of 
IL-6 is <6 hours. Even though our samples have been analysed using multiplex 
arrays, which is more suitable than ELISA, the use of multiplex arrays in clinical 
research remains limited. Multiplex results can be influenced by the abundance of 
proteins circulating, as bead-based multiplex array reactions take place in molecules 
and antigens, which are freely mobile in solution. As a result, multiplex arrays 
appear to be much more sensitive than ELISAs are to altered levels of circulating 
proteins and inhibitors. As many circulating proteins, may change their levels during 
aging, inflammation or disease, this can further complicate the picture. Therefore 
such new technologies need to be used with caution [130]. 
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Chapter 6: Conclusion 
 
The results of this study clearly show that DSP was safe and did not alter any 
tissue functions. This was shown by conducting an analysis of the biochemical 
parameters, histopathology and immune assay results. In addition, DSP exhibited a 
protective effect against oxidative stress in vivo, mainly due to its antioxidant 
potential and by strengthening the endogenous antioxidant system. Thus, DSP is a 
potential candidate for reducing the markers of oxidative damage, especially MDA, 
in bodily organs. DSP also did not alter the immune inflammation markers. This 
gives support to the safe consumption of DSP as well as suggesting its possible anti-
inflammatory effects. 
Therefore, if we consider the role of oxidative stress as a mechanism 
underlying chronic disease, it can be concluded that DSP can contribute to the 
prevention of these diseases. Although polyphenols are at least partly responsible for 
the effects of DSP in vivo, the underlying mechanisms require further investigation. 
Future experimental design should consider the true absorption and bioavailability of 
polyphenols, as well as the fact that during polyphenol digestion and absorption, they 
may undergo a considerable degree of chemical modification that can alter their 
biological properties and potency. Obviously, further studies are required to 
understand the effect of ROS on basic cellular functions. We also need to better 
understand how different cells respond to the ROS effect and how this, in turn, 
influences the pathology of different inflammatory diseases. 
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